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Abstract 
Saponins are high molecular weight glycosides, consisting of a sugar moiety 
linked to a triterpene or steroid aglycone. They have a very wide distribution in 
plants and some marine organisms. 
In this project, the anti-tumor and the cardioprotection activities of steroid 
saponins wil l be studied. DIAO is a mixture of steroid saponins extracted from 
Paris polyphylla and a pure steroid saponin, polyphyllin D which is designated 
as HK-18, is obtained by total synthesis. 
The objectives of the project can be divided into two parts. For HK-18, its 
.anti-tumor effect, mechanism involved in the cytotoxicity and its side effects 
would be investigated. On the other hand, for DIAO, its mechanisms involved in 
the myocardial protection and effect on the expression of various antioxidative 
enzymes in heart would be studied. 
The anti-tumour effect of HK-18 was studied by in vitro and in vivo 
models. By means of MTT assay, the survival of liver hepatoma cells (HepG2) 
and multidrug resistance hepatoma cells (R-HepG2) were recorded. Moreover, 
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in order to define the mechanisms involved, DNA fragmentation and cell cycle 
analysis with propidium iodide (PI) staining by flow cytometry were performed. 
Our results illustrate that the HK-18 mediated cytotoxic mechanism is related to 
apoptosis accompanied with G2/M cell cycle arrest. Besides, administration of 
HK-18 could suppress the growth of HepG2 cells in nude mice without causing 
any damage in the hearts of the hosts. 
On the other hand, in order to investigate the cardioprotective effect of 
DIAO, an in vivo model of isoproterenol (ISO)-induced myocardial injury were 
performed. ISO is a pi-adrenoceptor agonist, and wil l generate free radicals 
that cause cardiomyocytes damage when injected into animals. For the 
measurement, cardiac lactate dehydrogenase activity and the level of several 
antioxidant enzyme activities namely glutathione reductase and glutathione S-
transferase were investigated. The next part, ex vivo model - Langendorff isolated 
perfused rat heart system were employed to examine cardioprotective effect of 
DI AO. Rat hearts freshly isolated were perfused by the Langendorff method. 
The contractile force and the flow rate were recorded. Promising results in both 
in vivo and ex vivo experiments show that DIAO possess cardioprotective effect 
by increasing the level of antioxidative enzymes in heart resulting in lowering the 
peroxidation of the lipids components on the membrane of the myocytes. 
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At this moment, the action mechanism of DIAO in cardioprotection and that 
of HK-18 in treating the liver tumor are still not clear. Thus, more work need to 
be carried out to fully explore the use of these drugs on cardioprotection and 
cancer therapy. 
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Saponins are glycosides, consisting of a sugar moiety linked to a triterpene 
or steroid aglycone either by ether linkage or ester linkage. The structural 
variations of saponins lie in the attachment of different sugar groups to the 
aglycone part. 
Saponin possesses a distinct physical property, i.e. surface activity, like soap. 
Indeed, the name "saponin" originates from the Latin word "sapo" which means 
soap in English. 
Traditionally the definition of saponins is based on their surface activity due 
to their amphiphilic nature. Most saponins show detergent properties, due to the 
hydrophobic aglycone and the hydrophilic sugar moiety. They give stable foams 
in water, show hemolytic activity, have a bitter taste and are poisonous to fish. 
Saponins have antifungal activity and the primary mode of action towards fungi 
is similar to that of polyene antibiotics, involving the formation of complexes 
、 
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with membrane sterols. However many exceptions exist. Saponins are now more 
conveniently defined on the basis of their molecular structure, namely as 
triterpene or steroid glycosides. The most common sources of saponins are the 
higher plants, it is now known that over 90 families contain saponins (Gubanov 
et al., 1970) but increasing numbers are found in lower marine animals such as 
star fish (Vazquez et al., 1992). Their biological activities are closely related to 
the chemical structures that determine the polarity, hydrophobicity and acidity of 
compounds (Rao & Sun, 1995). 
1.2 Structure of Saponin 
Al l saponins have in common attachment of one or more sugar chains 
to the aglycone. The sugar chains may be linear or branched. The classification 
of saponins are based on the aglycone structure and can be classified into the 
following three classes. 
1.2.1 Triterpene Class 
In triterpene saponins, sugar groups often link at C-3 with an ether 
linkage and/or at C-28 with an ester linkage. This class of compound can be 
analyzed by selectively breaking the sugar chain at C-28 after alkaline 
hydrolysis. 
、 
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Fig. 1.1 Triterpene class 
1,2.2 Steroid Class 
The steroidal skeleton of steroidal saponins, containing 27 carbon atoms, is 
built up of six isoprene units and is derived from squalene. This class contains a 
basic structure as shown below. 
Fig. 1.2 Steroid class 
The steroid saponins are divided into two sub-groups, i.e., spirostanol 
glycosides and furostanol glycosides. 
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1.2.2.1 Spirostanol Glycoside 
3 丄 
Sugar cha in^^^- ' ' ' ' ^^ '^^ 
Fig. 1.3 Spirostanol Glycoside 
The spirostanol glycosides comprise of aglycones of the spirostan type. 
The sugar chain is attached at the C-3 position with an ether linkage. 
1.2.2.2 Furostanol Glycoside 
OH 
—Sugar chain b 
3 
Sugar chain 
Fig. 1.4 Furostanol Glycoside 
The furostanol glycosides are open chain glycosides. The sugar chains can 
be attached at the C-3 or C-26 positions through ether linkage. 
•s 
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1.2,3 Steroid Alkaloid Class 
The steroid alkaloid glycosides contain a basic structure as shown below. 
The sugar chain is often attached to the aglycone at C-3 position by an ether 
linkage. 
. H 
Fig. 1.5 Steroid Alkaloid Class 
1,3 Steroidal Saponin as Anti-Tumor Drug 
Saponins have been suggested to possess cytotoxic and antitumor 
activity. For example, a furostanol glycoside from Agavaceae, were found to be 
cytotoxic to cultured KB cells at 100|ag/ml, while the aglycone diosgenin is 
significantly more active and kills the cells at 10|ig/ml (Reddy et al.，1984). 
Three yamogenin glycosides from the seeds of Balanitaceae were found to 
exhibit cytostatic activity against the P-388 lymphocytic leukaemia cell line, with 
ED50 values of 0.41，2.40 and 0.21iig/ml respectively, while the diosgenin 
tetrasaccharide was found to exhibit ED50 0.22|ig/ml. These values of ED50 are 
•s 
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comparable with an ED50 value of 0.08|j,g/ml for the cancer chemotherapeutic 
agent 5-fluorouracil (Pettit et al., 1991). Solamargine and solasonine possess 
inhibitory effects against JTC-26 cells in vitro, while solamargine and khasianine 
exhibit cytotoxicity against human hepatoma PLC/PRF/5 cells (ED50 1.53}ig/ml 
and 8.60|ig/ml, respectively) (Lin et al., 1990). Cordyceps sinensis (冬蟲夏草） 
contains 2 steroid saponins that inhibit proliferation of malignant cell lines K526, 
WM-1341, HL-60 and RPMI-8226 by 10% to 40% at lOjig/ml (Bok et al., 1999). 
Steroid saponin from Lilium Speciosum (靈紅鹿子百合）exhibited anti-tumor 
promoter activity of HeLa cells (Nakamura et al” 1994). There are also other 
studies proving that steriodal saponins possess anti-tumor effect (Sata et al., 1998; 
Hu et al., 1996; Mimaki et al., 1999; Mimaki et al., 1998; Chiang et al., 1991; 
Crawford et al., 1995). 
1.4 Possible Anti-Tumor Action Mechanisms of 
Steroidal Saponin 
Biological activities of saponins are diverse and depend on the source 
and type of saponin. Studies have indicated that saponins possess anti-tumor 
properties through several mechanisms. Because of the heterogeneity in their 
chemical structures, it is hard to generalize about the biological activity of 
saponins. However, it is believe that the amphiphilic characteristics of saponins 
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influence their biological activity. 
1.4.1 Direct Cytotoxic and Growth Inhibitory Effects 
There are several in vitro and in vivo studies evaluating the cytotoxic 
effect of saponins against tumor development. Apart from the examples in 
section 1.3, extracts of a Chinese herbal drug, Yunan Bai Yao (雲南白藥)， 
exhibited cytotoxic activity in several cancer cell lines (Ravikumar et al., 1979). 
In a study of the anti-proliferation activity of ginsenosides using human prostate 
carcinoma LNCaP cell line, ginsenoside Rg3 induced classic apoptotic 
morphology and interfered with the expression of apoptosis-related genes, bcl-2 
and caspase-3 (Liu et al., 2000). In view of these observations, mechanisms 
involved in cytotoxicity of saponins may be related to apoptosis. 
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1.4.2 Immune-Modulatory Effects 
A digitonin saponin, formosanin-C, extracted from Liliaceae has been 
shown to have antitumor activity that acts by modifying the immune system (Wu 
et al., 1990). Intraperitoneal injection of formosanin-C inhibited the growth of 
hepatoma cells which were implanted in C3H/HeN mice. Analyze of blood 
samples from these animals showed that the activity of natural killer cells and the . 
production of interferon were significantly increased. The ginsenoside Rgi from 
the root of Panax ginseng was shown to increase both humoral and cell-mediated 
immune responses (Kenarova et al., 1990). Rgi increased the number of antigen-
reactive T helper cells and T lymphocytes and significant increases in natural 
killer activity and lymph node indexes were also observed in ginsenoside-treated 
animals. It would seem that saponins induce a series of immune responses rather 
than a single specific response. Although the mechanisms involved in the 
induction of cell proliferation by saponins are not clear, it is likely that saponins 
affect the cell membrane by directly binding to its components and affecting 
changes in transmembrane signals. Interactions of saponins with cell membranes 
can vary depending on the types of saponins and the cell membrane 
characteristics. 
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1.5 Possible Anti-Carcinogenicity Action 
Mechanism of Saponin 
1.5.1 Saponin binding to bile acids 
Apart from as the anti-tumor agents, saponins may also act to delay the 
initiation and progress of cancer. Metabolic epidemiological studies have shown 
a strong association between colon cancer incidence and a high concentration of . 
cholesterol metabolites and bile acids in the feces (Mower et al” 1979; Reddy 
and Wynder, 1973). There is convincing evidence of an interaction between 
saponins and bile acids (Malinow et al., 1979，Sidhu and Oakenfull, 1986). In 
vitro, saponins were shown to form large mixed micelles (1x10^ Da) with bile 
acids. Similar interactions in vivo would reduce the free form of bile acids in the 
upper gastrointestinal tract and lower the absorption of bile acids across the 
mucosa as well as the formation of secondary bile products from primary bile 
acids. These results suggest that saponins reduce the availability of bile acids to 
form secondary bile acids by intestinal microflora and therefore may prevent the 
development of colon cancer. 
1.6 Saponin as Cardioactive Drug 
It has been postulated that certain steroidal saponins have the ability to 
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Strength veins and decrease blood vessel permeability. Extracts of the rhizomes 
of Ruscus aculeatus are used in tablet form as a general vein tonic (Aubert and 
Anthoine, 1985). Another steroid saponins from Paris vietnamensis have 
chronotropic effects on the spontaneous beating of mouse myocardial cells. At 
0.016mg/ml, a triglycoside of diosgenin stimulated the cell beating rate in 
calcium-depleted cells by more than 80%. The same compound also stimulated 
calcium uptake by the myocardial cells (Namba et al” 1989). Researchers have . 
found that extracts of Butcher's broom, from the plant Suscus aculaetus, contain 
several steroidal saponin compounds that work as vasoconstrictors by activating 
alpha-adrenergic receptors. The main glycosides in butchers broom are called 
ruscogenins, which are known to possess anti-inflammatory properties in 
addition to being vasoconstrictive agents. These active ingredients reduce the 
fragility and permeability of capillaries and constrict the veins. Human clinical 
trials have supported the extracts effectiveness in treating vascular disorders, as 
well as its uses as an anti-inflammatory agent (http://www.viable-
herbal.com/herbdesc/lbutcher.htm). 
1.7 Liver Cancer 
Liver cancer (International Classification of Disease 155，9出 Revision) is 
a disease in which liver cells become abnormal, grow out of control, and form a 
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cancerous tumor. This type of cancer is called primary liver cancer. Primary liver 
cancer is also called hepatocellular carcinoma (HCC), which is the most common 
type of liver cancer. Very young children may develop another form of liver 
cancer known as hepatoblastoma. 
The development of liver cancer is believed to be related to infection with 
the hepatitis-B virus (HBV) and hepatitis-C virus (HCV). Scientists estimate that 
10 to 20 percent of people infected with HBV wi l l develop cancer of the liver. 
Moreover, 5 to 10 percent of people with cirrhosis of the liver (a progressive 
disorder that leads to scarring of the liver) wi l l eventually develop liver cancer. 
Other risk factors including alcohol consumption and malnutrition cause both 
cirrhosis and liver cancer, (http://www.nci.nih.gov). 
1.7.1 Prevalence of Hepatocellular Carcinoma 
Liver cancer occurs in over half a million people worldwide. From the 
world health report 1999，HCC is the third leading cause of death in all 
malignant neoplasms, which ki l l 0.59 million people every year 
(ht:tp://www.who.int/whr/2QQ0/en/statistics.htm). Moreover, China has the 
biggest share of liver cancer in the world. It is estimated that 60% of liver cancer 
deaths in the world occur in China. 
In Hong Kong, malignant neoplasm is the number one killer. Among 
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various cancers, liver cancer is the second commonest, which cause 12.5% of 
deaths in all types of cancer in 1998 (http://www.ha.org.hk). Besides, the survival 
time of patients with untreated HCC is short, the median survival time only 
ranging from a few weeks to a few months. Thus, there is a need to improve the 
current treatment as well as to explore new methods to treat liver cancer. 
1.8 Coronary Heart Disease (CHD) 
Coronary heart disease (CHD) or ischemic heart disease (IHD) 
(International Classification of Disease 410-414，9出 Revision) is defined as 
damage or malfunction of the heart caused by narrowing or blockage of the 
coronary arteries which supply blood to the heart muscles. Two of the clinical 
manifestations of CHD are angina pectoris (chest pain usually associated with 
effort or anxiety) and acute myocardial infarction (heart attack). Though often 
regarded as a "modem" disease, evidence of coronary occlusion could be dated 
back to Egyptian and Chinese communities two to three thousand years old 
(Department of Health, 1998). Nowadays, CHD is the predominant cause of 
mortality and disability in most developed countries, and is rapidly emerging as a 
serious health problem in many developing nations as well. 
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1.8.1 Prevalence and Risk Factors of CHD 
CHD is an extremely common disorder and the cause of most deaths in the 
world. In fact, report conducted by World Health Organization (1999) 
(http://www.who.int/ncd/cvd/index.htni) indicated that CHD is the top leading 
killer disease in richer nations and wi l l become much more common in 
developing countries. This report showed that at present circulatory disease kills 
17.0 million people a year or 30.3% of the annual total of deaths from all causes. 
Among the death tolls, 7.1 million were caused by CHD. In Hong Kong, heart 
disease ranked the second in the leading causes of death in 1998， 
(http://www.ha.org.hk) which is responsible for 5060 fatalities and 65.8% is 
CHD and IHD. On average, one Hong Kong citizen died of CHD in less than 2 
hours. Many of such deaths occur without warning in middle-aged men and 
women who are otherwise in good health. Therefore, more than 40% of victims 
suffering from acute myocardial infarction died before they had reached hospital. 
Although the exact cause of CHD is still unclear, certain risk factors are 
considered definite, including cigarette smoking, high blood pressure and 
hypercholesterolemia. Other possible risk factors are obesity, lack of physical 
activity, stress, genetic factor, diabetes mellitus and alcohol abuse (John, 1985; 
Tortora, et al., 1990). Due to the high incidence rate of CHD, there is an urge to 
develop new drugs in order to cure the disease. 
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1.9 Diosgenin 
Diosgenin, which is the most abundant existing steroidal saponin, is isolated 
and extracted from wild yam. Diosgenyl saponin provides about 50% of the raw 
material for making steroidal hormones such as estrogen, progesterone and 
cortisone by the pharmaceutical industry. In steroid synthesis, the carbohydrate 
moiety is usually split off from the 3-OH group during the isolation. Rings E and 
F of diosgenin can then be degraded to yield 20-oxo-5,16-pregna-dien-3beta-yl 
acetate (PDA), which is the material for the preparation of most types of steroid 
hormones, formed after a lengthy series of ring transformations. I f yam has 
steroidal effects on the body it is not because it contains steroidal hormones, but 
because the steroidal precursors have similar effects by an as yet unknown 
mechanism. The formula of diosgenin is C27H42O3 with molecular weight 414.69 
(http://www.healtliywave.com/ingredients/yamplant.html). 
Sugar chain——〇 
Fig. 1.6 Diosgenin saponin 
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1.10 Hong Kong Products 
HK products are a series of steroidal saponins synthesized by Professor 
Biao Yu, The Shanghai Institute of Organic Chemistry, Chinese Academy of 
Science. There are total 28 products, from HK-1 to HK-28. Al l of them are 
diosgenyl steroidal saponins, which contain the aglycone diosgenin. Diosgenyl 
saponins are the most abundant existing steroidal saponins. Because of their 
amphiphilic properties, all of them are only soluble in DMSO containing y-
cyclodextrin. After performing a screening test, data shown that among these 28 
products, HK-18 exhibited the most potent anti-proliferative effect on human 
liver hepatocarcinoma HepG2 cells. It exerts cytotoxic effect on HepG2 cells 
demonstrated by MTT test (data not shown). Hence, the cytotoxicity of HK-18 
wil l be one of the main themes of my project. 
1.10.1 HK-18 (Polyphyllin D) 
The scientific name of HK-18 is polyphyllin D. It has been isolated from 
Paris polyphylla (Liliaceae)(七葉一枝花）and other species. The rhizome of 
Paris polyphylla is a kind of Chinese herb, named Chong-lou (重樓)，produced 
in Guangxi, Sichuan, Yunnan and Shanxi provinces. In terms ofTCM, it is a mild, 
cold herb, with bitter flavor. Its active components enter the liver meridian, 
Introduction p. 16 
where it clears away heat, detoxifies, relieves asthma and cough, acting on the 
heart and liver channels, expels endogenous wind evil, and tranquilizes the mind. 
Pharmacological research shows that Paris polyphylla inhibits bacteria and 
coughing. Besides, it is used for treating tumors of the lung, stomach, liver, heart, 
urinary bladder and brain，leukemia and malignant lymphosarcoma, also cough, 
dysdrugpnea and infection of respiratory tract. It is also used for neurodermatitis, 
surgical infection and chronic bronchitis 
(http://www.healthphone.com/consump_english/encyclopedia/chinese_herbal—fil 
es/chonglou.htm). 
• • 1 1' 
Fig. 1.7 Paris polyphylla 
Paris polyphylla shows very promising cardiovascular and cytotoxic 
activities (Ma and Lau，1985; Namba et al, 1989; Zhou，1989). It has been 
reported that polyphyllin D (HK-18) possesses in vitro cytotoxic activities，i.e. its 
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ED50 on various tumor cells, namely mouse leukemia P-388, L1210 and human 
nasopharynx tumor KB cells are 0.44|Lig/ml, 0.43)ig/ml and 0.16|Lig/ml 
respectively (Zhou, 1989). 
HK-18 was purely synthesized by Professor Biao Yu (Deng et al. 1999; L i et 
al.，2001) by stepwise glycosylation. Its structure is diosgenyl a-L-
rhamnopyranosyl-( 1 ->2)-(a-L-arabinofuranosyl)-( 1 -^4)-p-D-glucopyranoside. 
The chemical formula of HK-18 is C44H70O16 with molecular weight 855.04. It is 
insoluble in water but is soluble in DMSO containing y-cyclodextrin. 
where sugar moiety: 
Glu OH 
Diosgenin n ^ V ^ 〇 \ Z 
\ OH 
o “ . H O - ^ O H Sugar chain— O 
Fig. 1.8 Structure of HK-18 
1.11 DI AO XIN XUE RANG (DI AO)(地奧心血康} 
DI AO is a Chinese herbal medicine, which is produced by Chengdu DI AO 
Pharmaceutical Group Co., Ltd., RR. China. Each pill contains lOOmg steroidal 
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saponins mixture in powder form extracted from a Dioscorea plant. According to 
the manufacturer, its main function is to eliminate the stagnancy and activate the 
blood flow, promote circulation and relieve pain, dilate the coronary arteries and 
improve the myocardical ischemia. It is mainly indicated for prevention and 
treatment of angina pectoris resulting from coronary heart disease, lung blockage 
caused by blood stagnated, pain in chest, palpitation and dyspnea. 
DI AO is a crude drug contains mainly diosgenin glycosides. It contains 8 
types of sterodial saponin, including HK-3, HK-5 and HK-9. Their structures are 
shown below. 
where sugar moiety: 
D i o s g函 GhpOH 
HK-3 
Sugar c h a i n ^ ^ ^ - ^ " " ^ ^ or 
r^u Glu ^OH 
^ ^ ^ H ^ l u HO 炒 
H O ： ^ ^ X a ^ o h 
HO HO HK-9 HO J O H 
Fig. 1.9 Structures of HK-3, HK-5 and HK-9 
、 
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There are several studies demonstrating the cardioprotective effect of DI 
AO. Mongrel dogs treated with DI AO showed that after ischemia - reperfusion, 
the changes on serum serotonin and plasma thromboxane B] was not significant 
comparing with normal animals. However, the level of these indices was 
significantly higher in the saline-treated group (趙丹，1994). The effect of DI AO 
on acute myocardial ischemia and hemodynamics caused by ligating coronary 
artery were studied in dogs. The results showed that DI AO reduced obviously 
the range and degree of myocardial ischemia, slowed down the heart rate, 
decreased the blood pressure, cardiac output, myocardial oxygen consumption 
and also increased the coronary arterial blood flow (劉建勛，1994). Other studies 
indicated that DI AO reduces the area of myocardial ischemia and degree of 
myocardial infarction, improved left ventricular systolic and diastolic functions 
and the antihypertensive effect is related to its negative and inotropic effect to the 
heart. DIAO even is good in improving cerebrovascular circulation (Yuan et al” 
1994;劉建勛,1994;李楊，1995;陳恒留，1994;瑪子玉，1994;郭雲庚,1994; 
呂岩，1996;趙丹，1997;王聖華，1998;包宗明，1998). 
Since DI AO was found to be cardioprotective, thus in my project I would 
like to investigate the mechanisms involved. Study on DI AO is the second 
theme of my project. 
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1.12 Aim of My Project 
In my project, it can be divided into two main sections. The first one is to 
study the effect of HK-18 on human hepatocellular carcinoma cells. And the 
second one is to examine the effect of DI AO on heart. 
The effect of HK-18 was investigated by in vitro and in vivo experiments. 
For the in vitro study, human hepatocellular carcinoma cell line, HepG2, was 
used. The anti-proliferative effect as well as the action mechanism of HK-18 was 
examined. For the in vivo study, HepG2-bearing nude mice model was used. 
Nude mice have impaired immune system. Thus, any effect on the tumor 
inoculated to the mice was due to the drug, but not the inborn immune response 
of the mice. 
The effect of DI AO was investigated by in vivo and ex vivo experiments. 
For both in vivo and ex vivo studies, rats would be pretreated with DI AO by 
force feeding. Then in the in vivo experiment, isoproterenol (ISO) would be 
injected to induced cardiotoxicity. The mechanisms involved in the 
cardioprotective effect of DI AO would be studied. For the ex vivo study, rat 
heart would undergo a myocardial ischemia-reperfUsion injury by using a 
Langendorff model. The protection afforded by DI AO would be examined also. 
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1.12.1 In Vitro Study of the Effect of HK-18 on HepG2 Cells 
In the in vitro study, the effect of HK-18 on the cell proliferation of HepG2 
cells was examined by MTT assay first. Then the action mechanism of HK-18 
was investigated. 
Since previous study suggested that saponins mediated its effect probably 
via the induction of apoptosis, analysis of cell cycle phase distribution was 
performed by flow cytometry with propidium iodide staining. To further confirm 
whether apoptosis took place upon HK-18 treatment, DNA fragmentation assay 
was carried out. 
1.12.2 In Vivo Study of the Effect of HK-18 by Human Liver Tumor 
HepG2 Cells-Bearing Nude Mice Model 
The effect of HK-18 was further studied by in vivo experiments using 
tumor-bearing nude mice model. HepG2 cells were inoculated to the mice and 
then HK-18 was injected to the mice intravenously. The anti-tumor effect of HK-
18 was examined by monitoring the tumor size and the tumor volume after the 
whole course of treatment. 
In the present project, the cytotoxic effect of HK-18 toward normal tissue 
was evaluated by measurement of the activities of plasma lactate dehydrogenase 
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(LDH) and creatine kinase (CK). LDH and CK are intracellular enzymes present 
abundantly in the myocardial muscle. In the case of myocardial damage, these 
two enzymes can leak out from the damaged myocardium. Therefore, LDH and 
CK leakage can act as biochemical parameters to assess the extent of myocardial 
injury. 
1.12.3 In Vitro Study of the Effect of HK-18 on Multidrug-Resistant 
Human Hepatocellular Carcinoma Cell Line, R-HepG2 
Multidrug resistant cancer cells may develop in parental cancer cells upon 
prolonged treatment with anticancer drugs. These cancer cells resist to drugs 
differing in chemical structures as well as mechanisms of influence on the cells. 
Among various multidrug mechanisms, overexpression of multidrug transporters, 
especially P-glycoprotein, is the commonest (Stavrovskaya, 2000). The 
appearance of multidrug resistance poses great barrier in the chemotherapy of 
cancer. As a result, numerous methods are developed to improve or reverse the 
multidrug resistance (Di Pietro et al., 1999; Ueda, et al., 1999 and Chan et al” 
2000). Thus, i f HK-18 is effective in treating multidrug-resistant cancer cells 
overexpressing P-glycoprotein, this wil l add value to HK-18 to serve as an 
anticancer drug. In view of this, HK-18 was tested for its ability in treating 
multidrug resistant hepatocellular carcinoma cells. 
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In the study of the effect of HK-18 on multidrug-resistant hepatocellular 
carcinoma, R-HepG2 cells were used. This cell line was developed by our group 
as described in the Materials and Methods. R-HepG2 cells were characterized 
with the overexpression of mdrl gene as well as P-glycoprotein (Chan et al., 
2000). The effect of on cell proliferation of R-HepG2 cells was examined by 
MTT assay and the mechanism of HK-18 was briefly studied by cell cycle phase 
distribution analysis and DNA fragmentation assay. Finally, HK-18 was tested for 
its possibility to act as a substrate to be bound and pumped out by P-
glycoprotein. 
1.12.4 Myocardial Ischemia-Reperfusion (IR) Injury in Isolated-Perfused 
Rat Heart Model 
When regional ischemia is developed from coronary occlusions that can 
initiate myocardial infarction, reperflision effected by thrombolytic drug, balloon 
angioplasty or coronary artery bypass, become routine and logical manoeuvre in 
the treatment of evolving myocardial infarction. However, it has become evident 
that such intervention may result in arrhythmias, myocardial stunning and cell 
damage that may limit the amount of potentially salvageable myocardium or 
even lethal consequences (Hess & Manson，1984; Simpson & Lucchesi，1987; 
Burton, 1988). In addition, similar consequences also resulted from a period of 
•s 
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global ischemia in-patients undergoing cardiac transplantation or open-heart 
surgery (Burton, 1988). The reintroduction of electrolytes, oxygen and cellular 
elements to the previously ischemic myocardium initiate lethal biochemical 
changes. In this respect, reperflision although essential for cell survival, caries 
with it the risk of inducing irreversible cell damage or cell death. "Ischemia-
reperfusion injury" is a term referring to this paradoxical phenomenon (Hess & 
Manson, 1984). 
The central role of the readmission of oxygen in the genesis of reperfusion 
injury has led to the suggestion that oxygen-derived free radicals and the 
consequent oxidative stress may contribute to reperfusion injury. Over the past 
10 years, direct observation of free radicals production during ischemia and 
reperfusion has been achieved by electron spin resonance (ESR) spectroscopy 
measurement using spin trapping techniques (Tossaki et al., 1990; Blasig et al” 
1994) in isolated heart (Arroyo et al., 1987; Maupoil & Rochette，1988; 
Shandelya et al., 1993). These studies showed an increased oxygen related free 
radicals production during the ischemia period, but even more so during the first 
few minutes of reperfusion when a sudden burst of free radicals production was 
observed. It has been proposed that the oxidation of cellular constituents by 
oxygen related radicals and other toxic oxygen metabolites, such as superoxide, 
hydrogen peroxide, etc, represents a major form of tissue injury that may occur 
in reperflised heart (Hess & Manson, 1984; Becker & Abrosio，1987). Moreover, 
、 
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the involvement of free radicals has been indirectly shown by the protective 
effect of antioxidant enzymes as well as free radical scavengers (Das & 
Engelman, 1990). Besides, the involvement of free radical-mediated damage has 
been supported by the presence of lipid peroxidation product in the reperfused 
myocardium (Rao et al., 1983). 
In the present study, a model of myocardial ischemia-reperfusion (IR) injury 
using Langendorff isolated-perfused rat heart system was established, which 
intended to simulate conditions of myocardial infarction. By using this model, 
the effectiveness of DI AO in the protection against myocardial IR injury would 
be studied. Myocardial IR injury was assessed by measuring the lactate 
dehydrogenase (LDH) leakage and the recovery of contractile force. Since in the 
case of myocardial damage, LDH can leak out from the damaged myocardium 
and the contractile performance wil l be deteriorated upon IR injury. Therefore, 
LDH leakage and recovery of contractile force can act as biochemical parameter 
and functional parameter, respectively, to assess the extent of myocardial IR 
injury. Alternations in myocardial antioxidant status were assessed by measuring 
the activities of myocardial antioxidant enzymes and myocardial GSH content. 
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1.12.5 Effect of DI AO Pretreatment on Global IR Injury 
For the ex vivo study, rat heart would undergo a myocardial ischemia-
reperfusion (IR) injury by using a Langendorff model. IR injury is characterized 
by the metabolic, electrophysiological, morphological and function derangement 
as well as by the sudden release of cytoplasmic constituents upon reoxygenation 
of the myocardium after a sustained period of ischemia. It is becoming 
increasingly evident that reactive oxygen species may play a significant role in 
the development of cell damage during IR injury (Dhaliwal et al.，1991). 
Therefore, the cardioprotection afford by DI AO would be examined by the 
indicators of LDH leakage and the contractile force recovery. 
1.12.6 Effect of DI AO Pretreatment on Isoproterenol-Induced Myocardial 
Injury in Rats 
In this experiment, isoproterenol (ISO) would be injected to induce 
cardiotoxicity. ISO is a potent pi-adrenoceptor agonist. Administration of a large 
dose of ISO (200mg/kg, i.p.) can induce intense stimulation of p-adrenergic 
activity. Under the ISO challenge, the rats develop a spectrum of 
pathophysiologic changes, which mimic myocardial infarction in human. These 
include dramatic increase in serum cardiac enzyme activities, temporary 
abnormal glucose tolerance, great excursions of aldosterone and corticosterone, 
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congestive heart failure as well as hypotensive shock (Wexler, 1985). The intense 
increase in cardiac output, occurring concomitantly with a greatly lowered 
peripheral resistance, wil l overwhelm the capacity of the coronary arteries and 
provide sufficient blood to sustain myocardial need for energy. As a result, 
ischemia and infarction can be supervened (Wexler, 1985). The histopathology of 
this myocardial infarct model is identical to that occurring spontaneously in 
arteriosclerotic rats and in spontaneously hypertensive rats. Most importantly, 
electrocardiogram tracings of rat hearts during ISO-induced myocardial 
infarction are identical to electrocardiogram tracings of human having 
myocardial infarction due to ischemia (Wexler, 1985). 
In order to examine the mechanisms involved in the cardioprotective effect 
of DI AO, rat would first be pretreated with DI AO, four hours after the injection 
of ISO, heparinized blood sample was obtained for plasma LDH assay. The 
entire myocardium was excised from the rat for preparing tissue homogenate and 
then several myocardial antioxidative enzymes and the myocardial GSH content 
would be measured. 





2.1.1 Cell Lines & Culture Medium 
2.1,LI Cell Lines 
Human hepatocellular carcinoma cell line, HepG2, was purchased from 
American Type Culture Collection. HepG2 cells were cultured in RPMI-1640 
medium (Sigma Chemical Company) with 10% (v/v) fetal bovine serum (Gibco 
BRL, USA), and 1% (v/v) antibiotics, penicillin/streptomycin (10，000units/ml) 
(Gibco BRL, USA). Cells were maintained at 37。C in a humidified atmosphere 
of 5% carbon dioxide/95% air. 
Multidrug resistant human hepatocellular carcinoma cell line, R-
HepG2, was developed in our laboratory. To develop resistant cells, HepG2 cells 
were incubated in stepwise increased concentrations of doxorubicin and resistant 
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cells were selected by removing those dead, non-adhesive cells. The resistant 
cells were cultured in RPMI-1640 medium with 10% (v/v) fetal bovine serum 
and 1.2}aM doxorubicin. The cells were maintained at 37°C in a humidified 
atmosphere of 5% carbon dioxide/95% air. The property of multiple drugs 
resistance was tested by treating the cells (HepG2 and R-HepG2) with different 
concentrations of anti-tumor drugs (doxorubicin, vincristine and methotrexate) 
for 48 hours and MTT assay was performed to determine the percentage survival 
of cells at each concentration. Upregulation of mdrl gene expression and 
overexpression of P-glycoprotein were confirmed by Northern analysis and 
Western analysis, respectively (Chan, et aL, 2000). 
2.1.1.2 Culture Medium 
Roswell Park Memorial Institute tissue culture medium 1640 
(RPMI 1640 medium). The powder was purchased from GIBCO-BRL. Each 
package containing phenol red, L-glutamine and 0.5mM HEPES was dissolved 
in I L of distilled H2O. Two grams of NaHCOj were supplemented to the 
medium. The pH of the medium was adjusted to 7.4. Medium was filtered by 
0.22|im bottle-top filter to ensure it was sterile. Cells were cultured in complete 
medium which contained 1% (v/v) penicillin-streptomycin (10,000units/ml) 
(GIBCO-BRL) and 10% (v/v) Bovine serum albumin (GIBCO-BRL). Medium 
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was stored at 4°C. 
2.1.2 Chemicals 
Doxorubicin (Sigma) was dissolved in dHsO (the stock concentration was 
5mg/ml) and stored at —20。C. 
HK-18 was total synthesized by Prof. Biao Yu, Shanghai Institute of Organic 
Chemistry, Chinese Academy of Science (Deng et al., 1999; L i et al , 2001). The 
pure drug was stored at 4°C until used. 
DIAO Xin Xue Kang (DIAO) was purchased from Chengdu DIAO 
Pharmaceutial Group Co. Ltd., P. R. China. Each pill contains lOOmg of steroidal 
saponins mixture in powder form and it was stored at 4°C until used. 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] 
It was purchased from Sigma and was dissolved in PBS at concentration of 5 
mg/ml. The solution was filtered by a 0.22|j,m Millipore filter. 
Propidium iodide (PI) was purchased from Sigma. PI was reconstituted in PBS 
with concentration of 2mg/ml. 
、 
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2.1.3 Buffers and Reagent 
Phosphate buffered saline (PBS) was prepared by mixing 136mM NaCl, 
2.7mM KCl, 1.5mM KH2PO4 and 8mM Na^PO* and adjusting the pH to 7.4. It 
was sterilized by autoclave and stored at 4°C 
DNA lysis buffer was prepared by mixing 200mM Tris-HCl (pH8.3) lOOmM . 
EDTA and 1% SDS in distilled water. 
Tris-acetate (TAE) buffer was first prepared as a SOX concentrated stock 
solution. It contained 242 g Tris base, 57.1 ml glacial acetic acid and 100 ml 0.5 
M EDTA (pH 8.0) in I L distilled water. 
Tris-EDTA (TE) buffer was prepared by mixing 10 mM Tris-Cl and ImM 
EDTA. The solution was adjusted to pH 7.4. 
Proteinase K (14 units/mg solid) and RNase A (59 Kunitz units/mg solid) were 
purchased from Sigma. Proteinase K was dissolved in distilled water in a 
concentration of lOmg/ml while RNase A was dissolved in TE buffer in a 
concentration of 0.2mg/ml. 
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6X DNA loading dye was prepared by mixing 0.25% bromophenol blue, 0.25% 
xylene cyanol FF and 30% glycerol in distilled water. 
SDS Lysis buffer was prepared by mixing 21|ig/ml aprotinin, 0.5|ig/ml 
leupeptin, 4.9mM MgCl�， ImM sodium meta-vanadate, 1% triton X-100 and 
ImM phenylmethylsulfonylfluoride (PMSF) in PBS. It was stored at room 
temperature. 
4X lower gel buffer was prepared by dissolving 90.8g Tris base and 2g SDS in 
400ml distilled water. The pH was adjusted to 8.8 with HCl. Then, distilled water 
was added to bring the solution to a volume of 500ml. 
4X upper gel buffer was prepared by dissolving 30.3g Tris base and 2g SDS in 
400ml distilled water. The pH was adjusted to 6.8 with HCl. Then, distilled water 
was added to bring the solution to a volume of 500ml. 
lOX SDS running buffer was prepared by dissolving 30.3g Tris base, 144g 
glycine and lOg SDS in IL distilled water. The concentrated stock solution was 
diluted 10-fold to give the working concentration. 
Tris-buffered Saline with 0.1% Tween-20 (TBS-T) lOX TBS stock was 
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prepared by dissolving 12.114g Tris and 87.66g NaCl in I L distilled water. The 
pH was adjusted to 8. The stock solution was then diluted 10 fold to give the IX 
working concentration. For IL IX TBS, 1ml Tween-20 was added. 
Saline was prepared by dissolving 0.9% NaCl (w/v) in distilled water. 
Homogenizing buffer was prepared by mixing 50mM Tris and O.lmM EDTA in 
distilled water. The pH was adjusted to 7.6 and stored at 4°C. 
2.2 Methods 
2.2.1 In Vitro Studies 
2,2,1.1 In Vitro Cytotoxicity 
2x104 cells per well were seeded on 96-well plate in lOOjal medium and 
incubated overnight. The medium was then replaced with different 
concentrations of HK-18 or doxorubicin. After 24hr or 48hr incubation, the 
medium of each well was discarded and cells were washed with PBS once. Then 
30 1^1 of 5mg/ml solution of MTT was added into each well and the plate was 
incubated at 37。C，5% CO: for 2hrs. After then, MTT solution was removed and 
lOOjil of DMSO was added in order to dissolve the crystal formed by the cells. 
Plates were incubated for further 30 min. Finally, plates were shaken for a while 
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and the optical density of each well was measured at 540 nm by an ELISA plate 
reader (BIO-RAD). 
The results were presented as percentage of survival 土 S.D. for the indicated 
number of different experiments. The percentage of survival cells was calculated 
by dividing the difference of the absorbance of treated cells and the absorbance 
of untreated cell and the value was multiplied by 100. 
Z2J.2 Cell Cycle Analysis by Flow cytometry 
Flow cytometer was used for cell cycle analysis with PI staining. Cells at 
7x105 per well were seeded in 6 well plate. Different concentrations of HK-18 
ranging from l\xM to S^M were added to the cells and incubated with 24hr or 
48hr. After treatment, cells were harvested and washed twice with PBS. Cells 
were then fixed with ice-cold 70% ethanol for at least 24hr. Then the cells were 
centrifiiged at 300 x g for 5 minutes and the cell pellet was resuspended in 800|il 
PBS, 100|il RNase A (lOmg/ml) and 20|al PI (2mg/ml). The mixture was 
incubated in the dark at 37°C for 30 minutes and was then analyzed by FACsort 
flow cytometer (Becton Dickinson). 'Cell Quest' program was used. The cell 
population was scanned by forward scatter (FSC) light and side scatter (SSC) 
light which reflected the size and the granularity of cells, respectively. Different 
phases of the cell cycle were assessed by collecting the signal at channel FL2-A. 
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The percentage of cell population at a particular phase was estimated by ModFit 
LT for Mac V.3.0. 
2,2,1.3 Maintenance of P-glycoprotein in R-HepG2 cells by doxorubicin and 
HK-18 
R-HepG2 cells were maintained in medium with 1.2 | iM of doxorubicin and 
HK-18 respectively and medium was changed in 3 times a week. Cells were 
harvested after 1 to 3 weeks. Protein extracts of treated cells were obtained by 
lysing the cells with 80|al lysis buffer and were stood in ice for 30 min. The 
samples were then boiled for 15 min and the protein content of each sample was 
estimated by bicinchonic acid (BCA) protein assay. Samples of 20-25 |ig were 
used to run sodium dodecyl sulfate-polyacrylamide gel electrophoresis. For 
detection of P-glycoprotein, 8% separating gel and 4.5% stacking gel were used. 
The proteins were then transferred to a polyvinylidene fluoride (PVDF) 
microporous membrane by semi-dry transfer system (BioRad). The membrane 
was blocked in 10% non-fat milk (in TBS-T) and stored at 4 °C overnight. The 
membrane was incubated in a dilution 1:200 (in TBS-T) of polyclonal rabbit 
antibody produced against P-glycoprotein. After 1 hr, the membrane was washed 
with TBS-T for three times and the antibody binding was visualized with 
horseradish peroxidase-conjugated anti-rabbit IgG in a dilution of 1:2000. 
Enhanced chemiluminescence (ECL) detection reagents (Amersham Pharmacia 
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Biotech) were used and the emitting signal was detected by exposure to 
autoradiography film (Kodak). 
2.2丄4 Assessment ofDNA Fragmentation 
DNA fragmentation assay was used to examine apoptosis. Treated cells 
(7x10^ per well) in a 6-well plate were washed with PBS twice. After then, the . 
cells were dissolved in 400 |il lysis buffer in a 1.5ml eppendorf tube. The tube 
was shaken until no cell debris left. Aliquots of 20 |al of 10 mg/ml proteinase K 
was added to each tube and incubated at 37 for at least 2 hr. The samples were 
cooled to room temperature and mixed with 150 saturated NaCl solution. The 
tubes were shaken vigorously and centrifuged at 6500 x g for 15 min. The 
supernatant was transferred to a new tube and mixed with 1 ml cold absolute 
ethanol. The mixture was then centrifuged at 15000 x g at 4 for 20 min. The 
DNA pellet was washed with 70% ethanol once and allowed to dry in oven. 
Finally, 20 |il TE buffer containing 0.2 mg/ml RNase A was added and 
incubated at 37 °C for 90 min. The samples were then electrophoresed in a 1.5 % 
agarose gel with ethidium bromide and electrophoresis at 80V for 1 hour and 10 
minutes. 
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2.2.2 In Vivo Assessment of the Anti-Tumor Activity of HK-18 
2.2.2,1 Animals and Tumor Inoculation 
Protocols relating to animal studies in this model have obtained the 
approval of the Animal Research Ethics Committee, The Chinese University of 
Hong Kong. Balb/c nu:nu nude mice (6-8weeks; 25-30g) of either sex were used 
as animal model. They were supplied by the Laboratory Animal Services Center 
of The Chinese University of Hong Kong under pathogen-free condition. Nude 
mice were housed in autoclaved cage with polyester fiber filters and kept on a 
12h-light/ 12h-dark cycle. Al l the diet and water had been autoclaved before 
feeding to nude mice. 
Suspension of 4x10^ of HepG2 cells were injected subcutaneously (s.c.) 
into the anterior back of athymic BALB/c mice 
2.2.2.2 Drug Administration 
Mice with inoculated tumor cells were randomly assigned into three groups, 
namely negative control group (only saline), solvent control group 
(0.0072%DMSO) and the treated group (2mg/kg HK-18). HK-18 was dissolved 
in 100% DMSO with the stock concentration of 555.66mM. The drug was 
prepared by diluting the stock with sterile saline. Al l the solutions were filtered 
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with 0.22|am filters. 
The treatment was started on the day after the inoculation of tumor cells. 
Drugs and saline were injected intravenously via the tail vein in 0.2ml for 10 
consecutive days. 
2.2.2,3 Assessment of the Tumor Size and Tumor Weight 
At the first day of drug treatment and at day 5 and day 10，the tumor size 
was measured and the volume of the tumor was monitored by a caliper. The 
tumor volume was calculated by the equation (Lew et al., 1999) shown as 
follows: 
Tumor volume (mm^) = a/2 x b/2 x h x tt 
where a, b and h are the minor and major dimensions and height, respectively 
The tumor was removed and its weight was recorded. 
2丄2.4 Plasma Preparation 
20mg of pentobarbital (Sigma) in 0.1-0.2 ml saline was injected into each 
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mouse. After the mouse was fainted, blood was drawn from the heart with a 
heparinized syringe. The blood was then centrifuged at 632x g for 15 minutes at 
4°C. Plasma were collected at the upper layer which appeared as a clear 
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yellowish solution. 
2.2,2.5 Measurement of the Plasma Enzyme Activity 
Plasma creatine kinase (CK) activity and Lactate dehydrogenase (LDH) 
activity were measured by CK kit and LDH-L kit (Sigma). The procedure was 
according to the manufacturer protocol. Plasma sample of 20jil and 50|il was . 
used for measuring the activity of CK and LDH respectively. The plasma sample 
was added to 1ml of corresponding reaction reagent in a cuvette and the reaction 
was monitored at 30。C for both CK and LDH. The change in absorbance at 
340nm was measured for 2 min for CK and 1 min for LDH. 
Plasma CK activity was calculated as follows: 
CK (U/U = (AA per min x TV x 1000) = AA per min x 8200 
6.22 X LP X SV 
Plasma LDH activity was calculated as follows: 
LDH (U/L) = (AA per min x TV x 1000) = AA per min x 3376 
6.22 X LP X SV 
Materials and Methods p.40 
2.2.3 Isoproterenol (ISO)-Induced Myocardial Injury (Rat 
Model) 
2.2,3.1 Animals 
Protocols relating to animal studies in this model have obtained the approval 
of the Animal Research Ethics Committee, The Chinese University of Hong 
Kong. Sprague-Dawley rats (8 weeks; 200-250g) were supplied by the 
Laboratory Animal Services Center of The Chinese University of Hong Kong 
under pathogen-free condition. Sprague-Dawley rats were fed with animal diet 
(PICO LAB® Rodent Diet) and tape water ad libitum. Al l animals are kept on a 
12h-light/ 12h-dark cycle. 
2.23.2 Drug Preparations 
2.5mg of Diao-Xin-Xue-Kang was dissolved in 1 ml distilled water to give 
a yellowish brown suspension. 
5mg ofcatechin (Sigma) was dissolved in 1 ml distilled water to give a clear 
solution. 
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2.2.3.3 Animal Treatment 
Male SD rats were randomly divided into 3 groups of at least 10 animals in 
each. In the DIAO group, animals were administered intragastrically with the 
DIAO suspension at 6mg/kg. Animals in the catechin group and the control 
group were treated with 12mg/kg catechin and 0.6 ml distilled water, 
respectively. 
Treatment was performed on the every day for ten days. On the next day 
after the last treatment, half of the animals from each group were subjected to 
isoproterenol challenge (200mg/kg, i.p.). A l l animals were then sacrificed at four 
hours after the isoproterenol injection. Heparinized blood samples were obtained 
from the ether-anesthetized animals by cardiac puncture. The hearts were then 
excised and homogenized for various enzyme assays. 
2.2.3.4 Preparation of Myocardial Tissue Homogenate 
The entire myocardium, excised from the ether-anesthetized animals in the 
ISO study was immediately placed in an ice-cold homogenizing buffer. The 
myocardium was then homogenized in homogenizing buffer (1:10，w/v) using 
two 10 second bursts of a Polytron PT 3100 homogenizer at 1 x 10^  rpm. A 
10-sec interval was allowed between the bursts in order to avoid overheating. 
•s 
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2.2.3.5 Preparation ofCytosolic Fraction of Heart Homogenates 
Cytosolic fraction was prepared by diluting the heart homogenates with the 
homogenizing buffer (1:3, v/v). The diluted mixture was centrifuged at 
106,200xgfor30minat4°C. 
2.2.3.6 Myocardial Antioxidant Enzyme Activity 
Myocardial antioxidant enzyme activity was measured using cytosolic 
fractions prepared from tissue homogenates. A l l assays were performed at 25 
unless otherwise indicated. 
2.2.3,6.1 Glutathione Reductase (GRD) 
Reaction mixtures contained 0.5 ml of 18 mM GSSG, 1 ml 0.45 M Tris-90 
mM EDTA (pH 7.6), an aliquot of 0.1 ml cytosolic fraction and sufficient H2O to 
make up a final volume of 2.9 ml. The reaction was initiated by the addition of 
100 |i l 3 mM NADPH solution and absorbance changes at 340 nm of the reaction 
mixture were monitored spectrophotometrically for 3 min. Enzyme activity was 
estimated using an extinction coefficient for NADPH at 340 nm of 
6.22 X lO'^ M'^ cm'^  and expressed as mU/mg tissue. One unit (U) represents the 
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activity of enzyme that can oxidize 1 ^ imole NADPH per min. 
2.2.3.6.2 Glutathione S-Transferases 
The glutathione S-transferases (GST) activity was measured with the 
reaction mixtures containing 1 ml of 1 M EDTA-0.1 M sodium phosphate buffer 
(pH 6.5), 50 |il of 20 mM GSH and 50 |LI1 of 20 mM 1 -chloro-2,4-dinitrobenzene 
(CDNB) (dissolved in 90% ethanol). The reaction was initiated by the addition of 
50 )il of cytosolic fraction and absorbance changes at 340 nm of the reaction 
mixture were monitored spectrophotometrically for 3 min at 30 °C. Enzyme 
activity was estimated using an extinction coefficient for CDNB at 340 nm of 9.6 
X 10-3 M.icm-i and expressed as mU/mg tissue. One unit (U) represents the 
activity of enzyme that can reduce 1 pinole CDNB per min. 
2,2,3,7 Myocardial Antioxidant Capacity 
2.2.3.7.1 Myocardial Malondialdehyde (MDA) Content 
Myocardial MDA content was determined with the assay mixture 
containing 0.5 ml 10% tissue homogenate, 0.5 ml cold 0.67% (w/v) 
thiobarbituric acid (TBA) (Sigma Chemical Co.) solution (in equal volumes of 
distilled water and glacial acetic acid), 225 |al distilled water, 50 [i\ butylated 
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hydroxytoluene (BHT) (Sigma Chemical Co.) (dissolved in isopropanol) and 250 
juil 4 mM ferric chloride (dissolved in 0.9% normal saline). The reaction was 
initiated by incubating the mixture at 90 °C for 30 minutes. After cooling, 2 ml of 
n-butanol was added. With vigorous mixing for 1 min and subsequent 
centrifugation at 400 x g at room temperature for 30 minutes, the butanol layer 
was taken for the measurement of absorbance at 532 nm and 453 nm. Tissue 
MDA content was estimated from a calibration curve (Li, 1996) using acid 
hydrolyzed 1,1,3,3-tetraethoxypropane (Sigma Chemical Co.) as standard and 
was expressed as mmole/g tissue. 
Concentration of MDA (nmole/mg tissue) = r ( A 5 3 2 - b l a n k ) - Q . 2 ( A 4 5 3 - b l a n k ) ' 
Slope X Wt 
where A532 = absorbance at 532nm 
A453 = absorbance at 453nm 
Slope = slope of standard curve 
Wt = total weight of tissue used 
2.2.3.7.2 Myocardial Thiol Content 
An aliquot (0.2 ml) of tissue homogenate was combined with 0.2 ml normal 
saline, 0.9% NaCl (w/v), followed by the addition of 0.1 ml ice-cold 
trichloroacetic acid (TCA) (25%, w/v). After centrifugation at 632 x g for 10 min 
at 4 an aliquot of 0.2 ml supernatant was obtained and added to 1 ml 0.1 M 
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phosphate buffer (pH 8.0). The colour reaction was initiated by adding 50 |il 
5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) (Sigma Chemical Co.) solution (3 
mM, prepared in the same phosphate buffer) and absorbance at 412 nm of the 
reaction mixture was measured after 5 minutes. The tissue thiol content was 
estimated from a calibration curve (Li, 1996) using GSH as standard (Sigma 
Chemical Co.) and was expressed as mmole/g tissue. 
2.2.3.7.3 tert-Butylhydroperoxide (tBHP)-lnduced Thiol Depletion 
Peroxide-induced thiol depletion was measured by incubating myocardial 
tissue homogenate with tBHR Reaction mixtures, containing 0.2 ml of 
myocardial tissue homogenates and 0.2 ml tBHP (dissolved in 0.9% normal 
saline) at a final concentration of 0.025 mM, were incubated at 37 °C for 30 
minutes. The reaction was terminated by adding 0.1 ml of 25% TCA (w/v), and 
the thiol content was measured as described in the previous section. 
2.2.3.7.4 tBHP-lnduced Thiobarbituric Acid-Reactive Substances 
(TBARS) Formation 
Aliquots of 10% tissue homogenate (0.4 ml) were incubated with an equal 
volume of tBHP in 0.9% normal saline (final concentrations 0.5 and 1 mM) for 
30 min at 37 Reactions were terminated by the addition of 0.4ml ice-cold 
TCA (28%, w/v) containing O.IM sodium arsenite. Following centrifligation at 
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632 X g, an 0.8ml aliquot of the supernatant was mixed with 0.4ml TBA solution 
(0.5% (w/v) in 0.025 M NaOH). The mixture was boiled at 90 °C for 15 minutes. 
The TEARS formed was estimated from the absorbance at 532 nm. 
2.2.4 Myocardial Iscbemia-Reperfusion (IR) Injury 
2,2.4.1 Langendorff Isolated Perfused Rat Heart 
2.2.4.1.1 Preparation of Perfusion Buffer 
The perfusion buffer was a modified Krebs-Henseleit bicarbonate solution 
(pH 7.4) containing 120mM NaCl, 25.4mM NaHCO]，4.8mM KCl, 1.2mM 
KH2PO4, 0.86mM MgS04, 1.25mM CaCl: and l l m M glucose. Perfusion buffer 
was freshly prepared on the day of experiment and was adjusted to pH 7.4. The 
buffer was then filtered through a 022\im Millipore filter before use. The 
normoxic perfusion buffer was gassed with a 95% 02-5% CO2 gas mixture 
(analytical grade, Hong Kong Oxygen Co.). 
2,2.4.1 _2 Preparation of Isolated Rat Heart 
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Control or drug pretreated male Sprague-Dawley rats (200-250 g) were 
anesthetized with diethylether. Hearts were then rapidly excised and immediately 
chilled in ice-cold and heparinized (50 unit/ml) 0.9% saline. The arrested heart 
was cannulated via the aortic root in a warm and moisturised chamber of the non-
recirculating Langendorff perfusion apparatus (Fig. 2.1). The heart was 
retrogradely perfused at a constant perfusion pressure regulated by a peristaltic 
pump. The heart and perfusion buffer were maintained at 37 °C via a constant 
temperature water-jacketing system. The apex of the heart was attached via a 
metal hook to an unextendable thread connected to a force displacement 
transducer (Grass FT03). Isometric contractions of the heart were recorded on a 
polygraph (Grass Model 7-8P), with a resting tension of 1.5 g. The isolated 
perfused rat hearts were allowed to a 20-min of normoxic perfusion for 
equilibration before the start of any experiment. 
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Fig. 2.1 Langendorflf Apparatus 
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2.2.4.1.3 Myocardial Globa丨 Ischemia-Reperfusion Injury 
After the 20 mins equilibration, the isolated heart was subjected to a 30-min 
period of "no-flow" normothermic global ischemia followed by a 15-min 
reperfusion. Isometric contractions of the heart were continuously recorded 
during the whole experiment. Coronary effluent sample was collected every 10 
min during the equilibration period, as well as every minute during the 
reperfusion. The samples collected were kept on ice until assay for the LDH and 
CK activity. 
2.2.4.1.4 Contractile Force Recovery 
The extent of contractile force recovery was estimated by the ratio between 
the height of the contractile force recording at the end of the reperfusion to the 
height of those at the end of the equilibration. The ratio was multiplied by 100% 
and the contractile force recovery was expressed in a percentage value. 
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2.2,5 Statistical Analysis 
Data were expressed as arithmetic mean 土 S.D.，unless otherwise specified.. 
Student's t test was performed in the experiment indicated and p<0.05 was 
considered as statistically significant when comparing the difference between the 
control and tested groups. 
、 
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Chapter 3 
Study of HK-18 
on 
Anti-Tumor Effect 
3.1 In Vitro Study of HK-18 on Human Hepatoma 
Carcinoma Cell Line (HepG2) 
In this chapter, in vitro experiments would be carried out in order to 
.examine the effect of HK-18 on hepatocellular carcinoma cell line, HepG2. The 
effect of HK-18 on cell proliferation was first to be examined by MTT assay. 
Then, the action mechanism of HK-18 was studied. DNA fragmentation assay 
and cell cycle analysis by flow cytometry with PI staining were performed in 
order to study the anti-proliferative effect of HK-18 so as to determine whether 
HK-18 was capable of inducing apoptosis. 
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3.1.1 The Effect of HK-18 on Cell Proliferation of HepG2 Cells 
by MTT Assay 
HepG2 cells were incubated with various concentrations of HK-18 and 
incubated for 24hr and 48hr (Fig 3.1). The results showed that HK-18 inhibited 
the cell proliferation of HepG2 cells in dose- and time-dependent manner. The 
IC50 of HK-18 on HepG2 cells after 24hr and 48hr incubation were 4.2|iM and 
1.0|iM respectively. 
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Fig. 3.1 The anti-proliferative activity of HK-18 on HepG2 cells by MTT 
assay. Cells were cultured with different concentrations of HK-18 for 24hr 
and 48hr. The IC50 at 24hr and 48hr incubation on HepG2 cells was 4.2|iM 
and l.OjiM respectively. Each point represents the value expressed by 
mean 士 SD of 5 determinations. 
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3.1.2 DNA Fragmentation Assay 
A ladder pattern shown in the DNA gel electrophoresis is a phenomenon 
of apoptosis. During apoptosis, caspase-activated deoxyribonuclease (CAD) is 
activated and cleaves the DNA into 30-500 kilobase-pair domain-sized fragments.. 
Most low molecular weight fragments are multiples of about 200 base-pair. This 
is due to the cleavage of DNA at the linker between nucleosomes (Reed, 2000 
and Hengartner, 2000). As a result, after applying gel electrophoresis, a ladder 
pattern is observed which indicates that apoptosis takes place. 
Fig 3.2 and fig 3.3 show the results of DNA fragmentation assay in typical 
experiments. When HepG2 cells were treated with different concentrations of 
HK-18, from Ij^M to 8|iM, a typical ladder pattern was observed in cells upon 3, 
5 and 8|iM of HK-18 after 24hr incubation. And after 48hr incubation, DNA 
ladders formed in cells under all concentrations of HK-18 treatment. 
、 
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Fig 3.2 Evidence of apoptosis appearing as a DNA ladder in agarose gel 
electrophoresis for HepG2 cells treated with different concentrations of HK-18 
after 24hr incubation. Lane 1: Control (untreated); Lane 2: 0.02%DMSO (solvent 
control); Lane 3: l^ iM HK-18; Lane 4: 3[iM HK-18; Lane 5: 5(iM HK-18; Lane 
6: 8fiM HK-18; M，500bp DNA molecular weight marker. 
Study of HK-18 on Anti-Tumor Effect p.56 
M 1 2 3 4 5 6 
_ 
Fig 3.3 Evidence of apoptosis appearing as a DNA ladder in agarose gel 
electrophoresis for HepG2 cells treated with different concentrations of HK-18 
after 48hr incubation. Lane 1: Control (untreated); Lane 2: 0.02%DMSO (solvent 
control); Lane 3: l^ iM HK-18; Lane 4; 3^iM HK-18; Lane 5: 5[iM HK-18; Lane 
6: 8|iM HK-18; M, 500bp DNA molecular weight marker. 
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3,1.3 The Effect of HK-18 on Cell-Cycle Phase Distribution 
From the results of MTT assay and the DNA fragmentation assay, it is 
indicative that HK-18 can inhibit the growth of HepG2 cells. In order to 
investigate the mechanism involved, flow cytometric analysis using propidium 
iodide fluorescence was performed to examine how HK-18 affects the 
distribution of HepG2 cells in different phases of the cell cycle. 
Fig 3.4 shows a typical histogram of cell-cycle phase distribution of cells 
which are without any treatment. The first peak represents 1 copy of DNA which 
indicates GO/Gl phase. The second peak represents 2 copies of DNA which 
indicates G2/M phase. The in-between plateau indicates S phase at which cells 
have 1-2 copies of DNA. 
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Fig 3.4 Cell Cycle Analysis of HepG2 cells without any treatment. 
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Fig. 3.5 and Fig. 3.6 show the results of typical experiments in the flow 
cytometric analyses. HK-18 treatment for 24 and 48 hr revealed that the 
percentage of cells in G2/M phase tended to increase with rising concentration of 
HK-18. In a sample that contained the pooled attached/floating cells, the 
proportion of HepG2 cells in G2/M phase was increased in cells exposed to at. 
least 3}iM of HK-18. From 63% of cells in GO/Gl phase, 20.61% in the S phase 
and 16.39% in the G2/M phase for the control, to 28.63%, 22.32%, and 49.05% 
for 8|iM, 24hr incubation of HK-18, respectively. Similar result was found in 
48 hr treatment also. Moreover, HK-18 also began to induce apoptosis with 5|iM 
and 3|aM after 24hr and 48 hr incubation respectively, as indicated by a sub-Gl 
peak in the histogram. These results suggest that HK-18-induced cell death was 
accompanied by G2/M cell cycle arrest and followed by apoptosis. 
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Fig. 3.5 Cell cycle analysis of HepG2 cells after treatment with different 
concentrations of HK-18 for 24hr. Cells were fixed with ethanol and stained with 
PI, and analyzed using flow cytometry. The level of G2/M phase arrest was 
increased in cells treated with HK-18 at 3[lM, 5|aM and SjiiM. An evident sub-Gj 
peak was observed in cells treated with HK-18 at 5|LIM and 8|iM. 
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Fig. 3.6 Cell cycle analysis of HepG2 cells after treatment with different 
concentrations of HK-18 for 48hr. Cells were fixed with ethanol and stained with 
PI, and analyzed using flow cytometry. The level of sub G! peak and G2/M phase 
arrest was increased in cells treated with HK-18 at 3[iM, 5|iM and 8|iM. 
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3.2 In Vivo Study of HK-18 on HepG2-Inoculated Nude Mice 
For the in vivo study, HepG2-inoculated nude mice were used. The anti-
tumor activity of HK-18 was studied by measuring the tumor volume and the 
tumor weight after the whole course of treatment. The mice were divided into 3 
groups, negative control group which received HepG2 cells inoculation with no 
drug but saline injection, solvent control group which received HepG2 cells 
inoculation and was injected with 0.0072% DMSO which is the final 
concentration of DMSO in HK-18 preparations. HK-18 treated group which 
received both HepG2 cells inoculation and 2mg/kg HK-18 injection. About 4 x 
106 cells were inoculated to the mice subcutaneously on their shoulders. The 
treatment was started one day after the inoculation and lasted for 10 consecutive 
days. 
3.2.1 Assessment of the Anti-Tumor Activity of HK-18 
During the treatment, the tumor volume was measured at day 1，5 and 10 by 
a caliper. Figure 3.7 shows that after HK-18 treatment (2mg/kg, 10 days), the 
tumor volume was significantly reduced when compared to those of the negative 
control group and the solvent control group. 
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Fig. 3.7 The effect of HK-18 on the tumor volume. The tumor volume of the 
HepG2-bearing nude mice was measured after the whole course of treatment. 
The negative control group was injected with saline, the solvent control group 
was injected with 0.0072% DMSO and the HK-18-treated group was injected 
with 2mg/kg HK-18 every day for 10 consecutive days. The tumor volume was 
calculated by the formula: a/2 x b/2 x h x TT, where a, b and h are the minor and 
major dimensions and height, respectively (Lew et al., 1999). Each group 
contained 5 mice. The statistical analyses were performed by Student's t-test. 
* significantly different (p<0.005) from negative control group. # significantly 
different (p<0.05) from solvent control group 
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Apart from the tumor volume, the tumor weight was also recorded. Fig. 3.8 
shows that the tumor weight of the HK-18 treated group was dramatically 
decreased compared to those of both control groups. This result is in parallel with . 
that of the tumor volume. 
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Fig. 3.8 The effect of HK-18 on the tumor weight. The tumor volume of the 
HepG2-bearing nude mice was measured after the whole course of treatment. 
The negative control group was injected with saline, the solvent control group 
was injected with 0.0072% DMSO and the HK-18-treated group was injected 
with 2mg/kg HK-18 every day for 10 consecutive days. Each sample contained 5 
mice. The statistical analyses were performed by Student's t-test. # significantly 
different (p<0.005) from negative control and solvent control group. 
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3.2.2 The Effect of HK-18 Towards Heart Tissue 
Numerous anticancer drugs like doxorubicin are reported to be 
cardiotoxic. Since HK-18 may be used to serve as an anticancer drug, it is 
important to examine whether HK-18 is non-cardiotoxic. Hence, the effect of 
HK-18 on the heart in HepG2 bearing nude mice was studied. The toxicity of 
HK18 on heart tissues was examined by the measurement of the activities of 
plasma LDH and CK enzymes in the heart. 
As shown in figure 3.9，the CK activity was more or less the same among 
the three groups. Besides, the LDH activity (Fig. 3.10) did not vary much in the 
negative control group, the solvent group and the HK-18 treated group. This 
result indicates that acute HK-18 treatment was non-cardiotoxic. 
、 
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Fig 3.9 The plasma CK activity upon HK-18 treatment. Nude mice were 
divided into 3 groups, all 3 groups have HepG2 cells inoculation. The negative 
control group was injected with saline, the solvent control group was injected 
with 0.0072%DMSO and the HK-18-treated group was injected with 2mg/kg 
HK-18. Plasma was prepared for measuring the CK activity after the whole 
course, namely 10 consecutive days, of treatment. Each group contained 5 mice. 
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Fig 3.10 The plasma LDH activity upon HK-18 treatment. Nude mice were 
divided into 3 groups, all 3 groups have HepG2 cells inoculation. The negative 
control group was injected with saline, the solvent control group was injected 
with 0.0072%DMSO and the HK-18-treated group was injected with 2mg/kg 
HK-18. Plasma was prepared for measuring the LDH activity after the whole 
course, namely 10 consecutive days, of treatment. Each group contained 5 mice. 
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3.3 In Vitro Study of HK-18 on Multidrug Resistant Cell Line 
(R-HepG2) 
Multidrug resistant cancer cells may develop upon prolonged treatment with 
anticancer drugs. These cancer cells resist to drugs differing in chemical 
structures as well as mechanisms of influence on the cells. Among various 
multidrug mechanisms, overexpression of P-glycoprotein, is the commonest one . 
(Stavrovskaya, 1999). In order to investigate the cytotoxicity of HK-18 against 
multidrug resistant cancer cells, the multidrug resistant human hepatocellular 
carcinoma cell line, R-HepG2, was used. R-HepG2 cell line was developed by 
our group and characterized that it exhibits overexpression of mdrl gene and P-
glycoprotein (Chan et al., 2000). In this chapter, the effectiveness of HK-18 on R-
HepG2 cells was studied. Firstly, the effect of doxorubicin (DOX), which is a 
common anticancer drug, on both the parental HepG2 cells and R-HepG2 cells 
was tested. Then the effect of HK-18 on cell proliferation of R-HepG2 cells was 
carried out. The action mechanism of HK-18 on R-HepG2 cells was briefly 
studied by analysis of cell-cycle phase distribution and DNA fragmentation assay. 
Finally, HK-18 was tested for its possibility to act as a substrate to be bound and 
pumped out by the P-glycoprotein. 
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3.3.1 The Comparison of the Cytotoxicity of DOX on the 
Parental Cells and Resistant Cells of HepG2 
In order to investigate the resistance of the cells, MTT assay was employed 
to compare the cytotoxicity of DOX on the parental cells (HepG2) and resistant 
cells (R-HepG2). The results show that HepG2 cells were sensitive to 
doxorubicin (Fig 3.11), which exhibited IC50 3.0|iM and l.O[iM to doxorubicin 
after 24 hr and 48hr incubation respectively. However, the ICsoOf doxorubicin on 
the resistant cells (R-HepG2) were 366|aM and 205|aM in 24hr and 48hr 
respectively (Fig. 3.12). This indicates that R-HepG2 cells were strongly 
resistant to doxorubicin. 
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Fig. 3.11 The anti-proliferative activity of DOX on HepG2 cells by MTT 
assay. Cells were cultured with different concentrations of DOX for 24hr 
and 48hr. The IC50 at 24hr and 48hr incubation on HepG2 cells was 3.0|iM 
and l.OpM respectively. Each point represents the value expressed by 
mean ± SD of 5 determinations. 
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Fig. 3.11 The anti-proliferative activity of DOX on R-HepG2 cells by MTT 
assay. Cells were cultured with different concentrations of DOX for 24hr 
and 48hr. The IC50 at 24hr and 48hr incubation on R-HepG2 cells was 
366^M and 205|iM respectively. Each point represents the value expressed 
by mean ± SD of 5 determinations. 
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3.3.2 The Effect of HK-18 on Cell Proliferation of R-HepG2 
Cells by MTT Assay 
R-HepG2 cells were incubated with various concentrations of HK-18 for 
24hr and 48hr. The results in Fig. 3.12 show that HK-18 inhibited the cell 
proliferation of R-HepG2 cells in dose- and time-dependent manner. The IC50 of 
HK-18 on R-HepG2 cells after 24hr and 48hr incubation were 2.8|iM and 1.4|iM 
respectively. 
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Fig. 3.13 The anti-proliferative activity of HK-18 on R-HepG2 cells by 
MTT assay. Cells were cultured with different concentrations of HK-18 for 
24hr and 48hr. The IC50 at 24hr and 48hr incubation on R-HepG2 cells was 
2.8|aM and respectively. Each point represents the value expressed 
by mean ± SD of 5 determinations. 
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3.3.3 DNA Fragmentation Assay 
Fig. 3.14 and Fig. 3.15 show the results of DNA fragmentation assay in 
typical experiments. When R-HepG2 cells were treated with different 
concentrations of HK-18, from l [ iM to 8|iM, a typical ladder pattern was 
observed in cells upon 3,5 and 8|iM after 24hr incubation. And after 48hr 
incubation, DNA ladders formed in cells under all concentrations of HK-18 
treatments. 
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Fig. 3.14 Evidence of apoptosis appearing as a DNA ladder in agarose gel 
electrophoresis for R-HepG2 cells treated with different concentrations of HK-18 
after 24hr incubation. Lane 1: Control (untreated); Lane 2: 0.02%DMSO (solvent 
control); Lane 3: l^iM HK-18; Lane 4: 3|iM HK-18; Lane 5: 5[iM HK-18; Lane 
6: S^iM HK-18; M, SOObp DNA molecular weight marker. 
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Fig. 3.15 Evidence of apoptosis appearing as a DNA ladder in agarose gel 
electrophoresis for R-HepG2 cells treated with different concentrations of HK-18 
after 48hr incubation. Lane 1: Control (untreated); Lane 2: 0.02%DMSO (solvent 
control); Lane 3: l[iM HK-18; Lane 4: 3[iM HK-18; Lane 5: HK-18; Lane 
6: S[iM HK-18; M, SOObp DNA molecular weight marker. 
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3.3,4 The Effect of HK-18 on Cell-Cycle Phase Distribution 
From the MTT assay, HK-18 was shown to be effective in inhibiting the 
cell proliferation of R-HepG2 cells. In this section, the mechanism of HK-18 on 
R-HepG2 cells was studied by cell-cycle phase distribution using flow cytometry 
with PI staining. 
Fig. 3.16 and Fig. 3.17 show the results of typical experiments of the flow 
cytometric analyses. HK-18 treatment for 24 and 48 hr revealed that the 
percentage of cells in G2/M phase tended to increase with rising concentrations 
of HK-18. The proportion of R-HepG2 cells in G2/M phase was increased in 
cells exposed to at least 3|a,M of HK-18. From 65.96% of cells in GO/Gl phase, 
20.35% in the S phase and 13.69% in the G2/M phase for the control, to 43.4%, 
23.8%, and 32.8% for 8}iM, 24hr incubation of HK-18, respectively. Similar 
result was found in 48 hr treatment also. Moreover, HK-18 also began to induce 
apoptosis with 5|iM and 3\xM after 24hr and 48 hr incubation respectively, as 
indicated by a sub-Gl peak in the histogram. These results suggest that HK-18-
induced cell death in R-HepG2 cells was accompanied by G2/M cell cycle arrest 
and followed by apoptosis. 
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Fig. 3.16 Cell cycle analysis of HepG2 cells after treatment with different 
concentrations of HK-18 for 24hr. Cells were fixed with ethanol and stained with 
PI, and analyzed using flow cytometry. The level of sub-Gj peak and G j M phase 
arrest was increased in cells treated with HK-18 at 5\iM and 8 _ . 
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Fig. 3.17 Cell cycle analysis of HepG2 cells after treatment with different 
concentrations of HK-18 for 24hr. Cells were fixed with ethanol and stained with 
PI, and analyzed using flow cytometry. The level of G2/M phase arrest was 
increased in cells treated with HK-18 at 3|iM, 5|iM and 8|aM. 
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3.3.5 The Relationship between HK-18 and P-glycoprotein 
From the above results, HK-18 was found to exhibit cytotoxic effect on R-
HepG2 cells. Moreover, the parental HepG2 cells and the R-HepG2 cells shared 
a similar sensitivity toward HK-18. Thus, in order to examine the mechanism 
involved, Western blot of P-glycoprotein was carried out, so as to clarify whether 
HK-18 was the target to be bound and pumped out by P-glycoprotein. The 
maintenance of P-glycoprotein expression in R-HepG2 cells by HK-18 was 
monitored for 3 weeks. 
R-HepG2 cells were treated with \2\xM of DOX and HK-18. The 
expression of P-glycoprotein was examined on week 1 and 3. The result of 
Western analysis in a typical experiment (Fig. 3.18) shows that the expression of 
P-glycoprotein began to decrease upon 1-week incubation with HK-18 and 
nearly disappeared after 4-week treatment. On the contrary, the expression of P-
glycoprotein of R-HepG2 cells was maintained when treating with DOX. This 
indicated that HK-18 may not be the substrate of P-glycoprotein and so, not like 
DOX, HK-18 cannot stimulate and sustain the expression of P-glycoprotein 
(Budworth, et al., 1997). 
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Fig. 3.18 Western analysis of the maintenance of P-glycoprotein upon 
various treatments. R-HepG2 cells were incubated with 1.2|iM DOX and 
HK-18 for 3 weeks and the expression of P-glycoprotein in the cells was 
examined on week 1 and 3. HepG2 cells were served as a negative control 
of P-glycoprotein expression. Lane 1: HepG2 cell; lane 2: R-HepG2 cells; 
lane 3: R-HepG2 cells incubated with 1.2^M of DOX for 1 week; lane 4: 
R-HepG2 cells incubated with l.2[iM of DOX for 3 weeks; lane 5: 
R-HepG2 cells incubated with l.2[iM of HK-18 for 1 week; lane 6: 
R-HepG2 cells incubated with l.2[xM of HK-18 for 3 weeks. 
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Chapter 4 
Study of the 
Cardioprotective 
Effect of DI AO 
4.1 Myocardial Ischemia-Reperfusion (IR) Injury in 
Isolated-Perfused Rat Heart 
4.1.1 Time Course of Global Ischemia-Reperfusion-Induced 
LDH Leakage 
In order to the study of IR-induced myocardial injury, the effect of global 
ischemia followed by 15 min oxygenated reperfiision on isolated perfused rat 
hearts was examined. Fig. 4.1 shows the result of a typical experiment. Thirty 
and 45 min of global ischemia followed by 5 min of oxygenated reperfiision 
caused a dramatic increase in the total LDH leakage from isolated perfused rat 
hearts. Global ischemia period greater than 45 min caused myocardial arrest 
(data not shown). In order to avoid irreversible damage to the myocardium, a 
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30-min of global ischemia followed by 15 min of oxygenated reperfusion was 
chosen as a model of ischemia-reperfusion (IR) injury in isolated perfused rat 
hearts. 
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Fig. 4.1 Time course of global IR induced LDH leakage. After an initial 
20-min of perfusion for equilibration, the isolated rat heart was subjected to a 
30-min or 45-min period of "no flow" global ischemia followed by a 5-min 
reperfusion. Values given are mean 士 SEM for 5 rats. 
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4.1.2 Effect of DIAO Pretreatment on Global IR Injury 
4.1.2.1 LDH Leakage 
As shown in Fig 4.2, reperfiision following a 30-min period of global no 
flow ischemia caused a dramatic increase in the extent of LDH leakage (259%) 
compared to the negative control group, which received no IR treatment. DIAO 
pretreatment (6mg/kg daily for 10 days) showed a significant reduction (61%) in 
IR-induced myocardial damage, as evidenced by the lower extent of LDH 
leakage which is similar to that produced by catechin pretreatment. 




:1a I I I I 
Neg. Control Water Catechin DIAO 
(12mg/Kg) (6mg/Kg) 
Fig 4.2 Plasma LDH activity upon DIAO pretreatment on global IR injury. 
Animals were pretreated with DI AO and catechin at the indicated dose for 10 
consecutive days. Values given are mean 土 SEM for 5 rats. Statistical analyses 
were performed by Student's t-test. * Significantly different (P<0.001) from the 
negative control group. # Significantly different (P<0.001) from the water group. 
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4.1.2.2 Contractile Force 
In addition, the IR-induced myocardial damage was associated with an • 
impairment in contractile force recovery during post-ischemic reperfusion. The 
extent of contractile force recovery was also increased significantly (120%) in 
DIAO-pretreated hearts (Fig. 4.3). 
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Fig. 4.3 Percentage recovery of contractile force at the end of the 15-min 
reperflision. Animals were pretreated with DI AO and catechin at the indicated 
dose for 10 consecutive days. Values given are mean 士 SEM, with the number of 
animals indicated in parentheses. The statistical analyses were performed by 
Student's t-test. * Significantly different (P<0.001) from the negative control 
group. # Significantly different (P<0.001) from the water group. 
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4.2 ISO-Induced Myocardial Injury in Rats 
Isoproterenol (ISO) is a synthetic catecholamine that stimulates both beta 1-
and beta 2-adrenergic receptors. Large dose of ISO in rat can cause intense 
stimulation of (31-adrenergic activity that results in a spectrum of 
pathophysiologic changes that mimic myocardial infarction in human wil l be 
developed in rats. For example, ISO would affect the heart by increasing . 
inotropic and chronotropic activity and autoxidation of ISO wil l generate free 
radicals that induced cardiomyocyte damage in the rat model. 
In this experiment, effect ofDIAO pretreatment would be studied in order to 
determine its cardioprotective activity against ISO-induced myocardial injury in 
rats. 
4.2.1 Effect of DIAO Pretreatment 
Fig. 4.4 shows that ISO injection (200 mg/kg, i.p.) could cause myocardial 
injury in rat, as indicated by a drastic increase in plasma LDH (71.9%) activities, 
4 hours after the injection. Pretreating rats with DIAO at a daily dose of 6mg/kg 
for 10 days protected against the ISO-induced myocardial injury, as evidenced by 
a significant reduction in plasma LDH (30.9%) activities which is similar to that 
produced by catechin pretreatment. 
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Fig. 4.4 Plasma LDH activity upon DIAO pretreatment with ISO challenge. 
Animals were pretreated with DIAO and catechin at the indicated dose 
for 10 consecutive days. Values given are mean 士 SEM for 3 rats. The 
statistical analyses were performed by Student's t-test. * significantly 
different (p<0.05) from Water-Control group. # significantly different 
(p<0.05) from Water-ISO group 
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4.2.2 Alternations in the Activity of Myocardial 
Antioxidant Enzymes 
In order to determine i f the cardioprotective effect afforded by DIAO was 
mediated by changing the activities of antioxidant enzymes, activities of 
myocardial glutathione reductase (GRD) and glutathione S-transferase (GST) 
were measured. As shown in figure 4.5 and 4.6，ISO treatment (200 mg/kg, i.p.) 
caused a significant change in the activities of GRD, which reduced in 68.6%, 
but it did not affect the activities of GST. Moreover, DIAO pretreatment was 
associated with an dramatic increase in the activities of GRD (290%) and GST 
(58.6%). On the other hand, catechin pretreatment did not affect GRD activity 
but activate GST activity. 
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Fig. 4.5 Effect of Acute DIAO Pretreatment on Myocardial Glutathione 
Reductase (GRD) Activities. Animals were pretreated with DI AO and 
catechin at the indicated doses for 10 consecutive days. Values given 
are mean 土 SEM for 3 rats. The statistical analyses were performed by 
Student's t-test. * significantly different (P<0.05) from the 
Water-Control group. # significantly differently (p<0.01) from the 
Water-ISO group. 
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Fig. 4.6 Effect of Acute DIAO Pretreatment on Myocardial Glutathione S-
Transferase (GST) Activities. Animals were pretreated with DI AO and 
catechin at the indicated dose for 10 consecutive days. Values given are 
mean 土 SEM for 3 rats. The statistical analyses were performed by 
Student's t-test # significantly different (p<0.05) from the Water-ISO 
group. 
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4.2.3 Alternations in Myocardial Antioxidant Capacity 
Myocardial antioxidant capacity was assessed in terms of tissue thiol and 
MDA content as well as the susceptibility of tissue homogenates to in vitro 
peroxide-induced thiol depletion and TEARS formation, which is an indirect 
index of lipid peroxidation. 
As shown in Table I, ISO treatment (200 mg/kg, i.p.) caused a significant 
increase in the extent of thiol depletion but no observable changes were found in 
tissue MDA level as well as in the myocardial thiol level and TEARS formation, 
when compared with the control group. Acute DIAO pretreatment (6mg/kg daily 
for 10 days) did not alter the myocardial thiol and MDA levels in ISO-treated 
animals. Myocardial tissue susceptibilities to peroxide-induced thiol depletion 
and TEARS formation were significantly decreased with 14.6% and 25.5% 
respectively after acute DIAO treatment. On the other hand, catechin 
pretreatment cause a significant increase in tissue MDA level but it did not affect 
the myocardial thiol level and TEARS formation. 
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MDA {mmole/g TBARS Thiols Peroxide-induced 
tissue) formation (mmole/g thiol depletion (%) 
( A 5 3 2 ) tissue) 
Water-CON 0.0057 土 0.0015 3.94 土 0.27 1.69 + 0.11 60.153 土 0.055 
Water-ISO 0.0086 土 0.0055 4.20 土 0.20 2.00 土 0.07 79.783 + 0.024 # 
DI AO-CON 0.0056 土 0.0015 3.21 土 0.113 1.87 + 0.08 66.774 + 0.053 
6mg/Kg 
DI AO-ISO 0.0156 土 0.0044 3.13 土 0.24* 2.16 + 0.05 68.116 土 0.108 * 
6mg/Kg 
Catechin- 0.0188 土 0.020 * 4.20 土 0.30 1.99 + 0.07 76.785 土 0.032 
IS012 “ 
mg/Kg 
Table 1 Effect of Acute DIAO Pretreatment on Myocardial Antioxidant 
Capacity. Animals were pretreated with DI AO and catechin at the indicated dose 
for 10 consecutive days. Values given are mean 士 SEM. The statistical analyses 
were performed by Student's t-test. * significantly different (p<0.05) from 
Water-CON group. # significantly different (p<0.05) from Water-ISO 
group. 
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Chapter 5 
Discussion 
S.lThe Significance of the Study of Saponin in the 
Treatment of Liver Cancer and Heart Injury 
Recently, the studies of chemotherapy of cancer by natural products are 
of great interest. HK-18 (polyphyllin D) is a steroid saponin which has been 
tested on various mouse leukemia tumor cell lines, including P-388 and L1210 
and human nasopharynx tumor KB cells (Zhou, 1989). This preliminary result of 
the medicinal effect of HK-18 is of great clinical significance. In the present 
study, I have explored the probable use of HK-18 in the treatment of human liver 
cancer. 
Liver cancer is the second commonest cancer in Hong Kong. The current 
method in the treatment of liver cancer is surgical resection, radiotherapy as well 
as chemotherapy. However, there are some limitations of each method. Surgical 
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resection of the liver involves taking out the part of the liver where the cancer is 
found but provided that the cancer is restricted to a particular region. A liver 
transplant is the removal of the entire liver and replacement with a healthy liver 
donated from someone else but only very few patients with liver cancer are 
eligible for this procedure and it is also very difficult to recruit suitable donors. 
Radiation therapy is the use of x-rays or other high-energy rays to kil l cancer 
cells and shrink tumors. It may also be given by attaching radioactive substances 
to antibodies (radiolabeled antibodies) that search out tumor cells in the liver. 
Radiation therapy is under the criteria that the cancer must be restricted to a 
particular region but cancer may metastasize to other regions at the later stage of 
cancer development. Chemotherapy is the use of drugs to kil l cancer cells. 
Chemotherapy for liver cancer is usually put into the body by inserting a needle 
into a vein or artery. This type of chemotherapy is called systemic treatment 
because the drug enters the bloodstream, travels through the body, and can kill 
cancer cells outside the liver. In another type of chemotherapy called regional 
chemotherapy, a small pump containing drugs is placed in the body. The pump 
puts drugs directly into the blood vessels that go to the tumor. For chemotherapy, 
doxorubicin (DOX) and methotrexate are more commonly used. However, side 
effects like toxic hepatitis and heart damage may result and hepatocellualr 
Discussion p. 98 
carcinomas generally do not respond well to chemotherapy. Moreover, prolonged 
treatment with these anti-cancer drugs may give rise to multidrug-resistant cancer 
cells, in turn, poses great obstacle in the cancer therapy (Fisher, 1994). Therefore, 
agents capable of inducing apoptosis, inhibiting cell proliferation, or modulating 
signal transduction are currently used for the treatment of cancer (Kyle et al., 
1997), and a combination use of multiple chemopreventive agents or agents with 
multiple targets are considered to be more effective (Hong and Spom, 1997). 
On the other hand, the incidence rate of coronary heart disease in Hong 
Kong is high, ranking the second in leading cause of death in 1998. Conventional 
therapeutic strategies are drug treatment and surgery. A variety of drugs are 
available for improving the blood flow through coronary arteries. Anticoagulant 
drugs have been used for minimizing clotting and embolus formation in arteries. 
I f the heart's pumping action is weak, it may sometimes be improved by 
reducing the heart workload. These drugs include glyceryl trinitrate and other 
nitrates, beta-blockers, calcium channel blockers, and peripheral vasodilator 
drugs. Unfortunately, the therapeutic effect of these drugs is far from satisfactory 
since the damage to coronary arteries as well as myocardial tissue has already 
been done. Anticoagulant drugs have little or no effect on the progress of the 
disease while vasodilator drugs are helpful in providing symptom relief but are of 
、 
Discussion p. 99 
no curative value. I f drug treatment fails to relieve the symptoms, or i f 
examination shows severe narrowing of coronary arteries, such high-risk 
situations should be dealed by surgical treatment. Blood flow may be improved 
by balloon angioplasty in which the narrowed part of the artery is stretched apart 
by an inflated balloon. The blood supply to the heart muscle can be restored by 
coronary artery bypass. By attaching a vein graft to the aorta and to a point on 
coronary artery below the blockages, the narrowed or blocked section of the 
coronary artery can be bypassed. However, it has become evident that such 
intervention may result in arrhythmias, myocardial stunning and cell damage that 
may limit the amount of potentially salvageable myocardium or even lethal 
consequences (Hess and Manson, 1984; Simpson & Lucchesi，1987; Burton, 
1988). In addition, similar consequences also resulted from a period of global 
ischemia inpatients undergoing cardiac transplantation or open-heart sugery 
(Burton, 1988). The reintroduction of electrolytes, oxygen and cellular elements 
to the previously ischemia myocardium initiates lethal biochemical changes. In 
this aspect, reperfusion is although essential for cell survival, it carries the risk of 
inducing irreversible cell damage or cell death. Moreover, it is suggested that 
oxygen-derived free radicals and the consequent oxidative stress may contribute 
to reperfusion injury. Therefore, new antioxidants from natural products are 
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needed to explore which can display a new model of action in protecting against 
free radical attack. 
Herbal therapy has thus been introduced partly because herbs consist of 
constituents with multiple targets, and partly because there is a long traditional 
using herbs in Asian and European countries. 
Saponin is one of the commonly studied plant constituents, although the 
underlying mechanism is not clear, many of them possess anti-tumor and 
cardioprotective effect. Hence, discovery of new saponin drugs for the treatment 
of liver cancer and heart disease is essential and important. 
From the present study, both the results of in vitro and in vivo 
experiments showed that polyphyllin D, which is designated HK-18, was 
effective in inhibiting the growth of human hepatocellular carcinoma cells, 
HepG2, via apoptotic mechanism. Moreover, it is also effective in inducing 
apoptosis of the multidrug-resistant hepatocellular carcinoma cell line, R-HepG2. 
This may shed some light on the use of HK-18 in the treatment of liver cancer. 
Besides, DI AO, a Chinese herbal drug, which consists of saponin mixture, also 
shows cardioprotective effect by modulating the myocardial glutathione 
antioxidant status. Hence, DI AO is a potential drug to prevent heart disease. 
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5.2Effect of HK-18 on Human Hepatocellular 
Carcinoma Cell 
One of the main aim of the present investigation was to explore the effect of 
HK-18 on cell growth and the induction of apoptosis in a human hepatocellular 
carcinoma cell line, HepG2. The effect of HK-18 on HepG2 was investigated by 
in vitro and in vivo studies. The results of in vitro study showed that HK-18 was 
effective in inhibiting the proliferation of HepG2 cells in a dose- and time-
dependent maimer. The IC50 of HK-18 on HepG2 upon 24hr and 48hr treatment 
was 4.2|aM and l.OjLiM，respectively (Fig. 3.1). 
For the in vivo study, nude mice bearing HepG2 cells were used as the 
animal model. Nude mice have impaired immune system. Thus, any effect on the 
human tumor bearing on the mice was due to the drug, but not the inborn 
immune response of the mice. The result of the in vivo study showed that HK-18 
exhibited a strong anti-cancer effect because it caused a statistically significant 
reduction in both the tumor size and the tumor volume (Fig. 3.7，3.8). 
In sum, results of both in vitro and in vivo studies showed that HK-18 was 
effective in inhibiting the growth of human hepatocellular carcinoma, HepG2 
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cells. 
5.3 Mechanism Study of Anti-Tumor Effect of 
HK- 18 
The present study demonstrates that HK-18 possesses growth-inhibitory 
capability against HepG2 cells. This finding is in agreement with previous 
studies showing that HK-18 inhibits the growth of cultured cell lines derived 
from human carcinomas of the nasopharynx (KB cell) and mouse lymphocytic 
leukemia (L1210 cell and P-388 cell) (Zhou, 1989). Further investigation was 
performed to determine whether the cytotoxic effect was mediated via an 
apoptotic mechanism. As evidenced by characteristic DNA fragmentation assay 
through gel electrophoresis (Fig. 3.2, 3.3) and measurement of subdiploid DNA 
contents and cell cycle phase analysis through flow cytometry (Fig. 3.5, 3.6). It 
appears that G2/M cell cycle arrest and leads to apoptosis are the main 
mechanism for cell killing in the presence of HK-18. 
Mammalian cell systems prevent carcinogenesis against genotoxic stress by 
at least two different mechanisms, i.e., by eliminating damaged cells through 
induction of apoptosis and by evoking cell cycle arrest, eliciting DNA repair 
systems. 
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Apoptosis is a fundamental mechanism for the deletion of unwanted, 
senescent or damaged cells. During apoptosis, cells are fragmented into small 
membrane-bound bodies with intact organelles and plasma membrane (Rust and 
Gores, 2000). Ordered DNA fragmentation is a biochemical characteristics of 
apoptosis. Endonucleases first cleave the DNA into large 50- to 300-kb pieces 
and then further into smaller 180-200 base pair fragments, which are responsible 
for the classic ladder pattern found in most apoptotic cells and the detection of 
subdiploid DNA content by flow cytometry. 
On the other hand, mammalian cells respond to DNA damage by activating 
cell cycle checkpoints. Each checkpoint control is involved in a temporary arrest 
in a specific stage of the cell cycle to allow the cell to correct any defects 
(Elledge, 1996). Two main checkpoints exist in mammalian cells, at G1 before 
entry to S and at G2 before entry to mitosis (O'Loughlin et al” 2000). 
In the present study, a typical DNA fragmentation was found upon HK-18 
treatment at 3\iM after 24hr incubation (Fig. 3.2) and I f iM of HK-18 was 
capable to induce apoptosis after 48hr incubation (Fig. 3.3). Moreover, the 
intensity of DNA fragments formed was in time- and dose-dependent manner, 
with the amount of DNA ladder increases at high concentrations of HK-18 (8|iM) 
treatment. 
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In addition, the mechanism involved was further demonstrated by cell cycle 
phase distribution using flow cytometry. HepG2 cells damaged by HK-18 tend to 
choose G2/M checkpoint, like other many chemotherapeutic drug such as 
doxorubicin (O'Loughlin et al., 2000)，allowing the repair systems to function 
before mitosis. To conclude, the data indicate that HK-18 induced apoptosis in 
HepG2 cells is accompanied by G2/M cell cycle arrest. 
There are several mechanisms involved in apoptosis. In the execution phase, 
caspases dismantle the cell by sequential activation and cleavage of key proteins 
(Cohen, 1997). Caspases are present in the cytosol of most cells as zymogens and 
need to be activated to fully functional proteases by cleavage of the proenzyme 
by proteolytic steps. Certain caspases (caspase-3, -6，-7) are called effector or 
downstream caspases, because they cleave key substances and eventually lead to 
apoptotic cell death. Currently, two major pathways are known to activate these 
effector caspases. One involves death factors and death receptors, the other 
mitochondrial dysfunction (Green, 1998). 
Death receptors are members of the tumor necrosis factor (TNF) 
superfamily. To date, TNF receptor-1 (TNF-Rl) and Fas (CD95/APO-1) are best 
characterized. Upon activation by their ligands, the death complex then activate a 
class of apical caspases, most notably caspase-8, which subsequently activates 
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the downstream effector caspases (Faubion and Gores, 1999). 
In the second pathway, cellular stress can trigger release of cytochrome c 
from mitochondria, which is probably mediated by permeability changes of the 
inner mitochondrial membrane potential (Green and Kroemer, 1998). 
Cytochrome c then binds to Apaf-1, which in turn activates caspase-9 and trigger 
the downstream caspases. 
Several cytoplasmic proteins are critically involved in the regulation of 
apoptosis, in particular members of the p53 and Bcl-2 family. Therefore, in order 
to clarify the mechanism involved in the apoptotic effect induced by HK-18, 
further investigations on the expression of caspases, death receptors and 
cytoplasmic proteins are needed. 
5.4 Cytotoxicity of HK-18 Toward Normal Tissues 
HK-18 exhibited strong anti-tumor activity but the safety problem that 
whether HK-18 has any side effects was still unclear. Heart damage is a common 
side effect of chemotherapeutic drugs, such as doxorubicin. In the present project, 
the cytotoxic effect of HK-18 toward heart was evaluated by measurement of the 
activities of plasma enzymatic markers of heart injuries. The results showed that 
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there was no significant difference between the normal, the negative control and 
the treated groups (Fig.3.9, 3.10). These results suggests that HK-18 at the 
dosage of2mg/kg did not damage the heart in the animal study. 
5.5 Effect of HK-18 on Multidrug Resistant Human 
Hepatocellular Carcinoma 
Clinical resistance to chemotherapeutic drugs is an important problem in the 
treatment of cancer. Tumor cells can acquire resistance to a wide variety of 
unrelated cytotoxic drugs when the tumor cells are exposed to a 
chemotherapeutic agent for a prolonged period. This phenomenon is called 
multidrug resistance (MDR). The molecular basis of a major form ofMDR is the 
overexpression of P-glycoprotein (P-gp), a 170-kDa plasma membrane protein. 
P-gp acts as an adenosine 5'-triphosphate (ATP)-dependent efflux pump for 
several structurally and fiinctionally unrelated cytotoxic drugs (Sharom et al., 
1999； Di Pietro et al., 1999). The circumvention of resistance to chemotherapy 
has become one of the primary goals of modem approaches to cancer therapy. 
Moreover, several chemotherapeutic drugs kil l drug-sensitive cells by apoptosis 
(Diaconu et al., 1999). 
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The multidrug-resistance human hepatocellular carcinoma cell line (R-
HepG2) used in recent studies was developed in our laboratory, which was 
characterized with upregulation of mdrl gene and overexpression of P-
glycoprotein (Chan et al” 2000). 
The results showed that HK-18 was effective in inhibiting the cell 
proliferation of R-HepG2 cells in a dose- and time-dependent manner (Fig. 3.13) 
and acted through induction of apoptosis as shown in a typical DNA 
fragmentation in gel eletrophoresis (Fig. 3.14, 3.15). It was accompanied with 
G2/M cell cycle arrest in cell cycle analysis. Moreover, R-HepG2 cells acquired 
similar sensitivity toward HK-18 as that of the parental HepG2 cells. This 
suggested that HK-18 was not a target of P-glycoprotein. This finding is of great 
clinical significance because this can help explore the potential use of HK-18 in 
treating patients with multidrug-resistance. In order to further investigate whether 
HK-18 was the target to be bound and pumped out by P-glycoprotein in R-
HepG2 cells, the maintenance of P-glycoprotein expression in those cells was 
monitored for 3 weeks upon treatment with HK-18 and doxorubicin (DOX). This 
was due to the reason that expression of P-glycoprotein could be stimulated and 
sustained by its substrate (Budworth et al , 1997). The result showed that the 
expression of P-glycoprotein of R-HepG2 cells began to drop upon treatment 
、 
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with HK-18 for 1 week and nearly disappeared after 3-week incubation. On the 
contrary, the expression of P-glycoprotein was maintained when R-HepG2 cells 
were incubated with DOX (Fig. 3.18). This may demonstrate that HK-18 is not 
the target of P-glycoprotein and so it cannot stimulate and sustain the expression 
of P-glycoprotein. 
Overexpression of P-gp in cancer cells is considered to be one of the major 
obstacles to successful chemotherapy. Cancer cells exhibit cross-resistance to a 
series of structurally unrelated drugs (Gottesman & Pastan，1993; Endicott & 
Ling, 1989). The only common features among these compounds are their 
hydrophobicity, their high size and a positive charge at neutral pH generally 
carried by a nitrogen atom (Tang et al., 1993). Many efforts have been 
undertaken in the search for compounds which are able to inhibit the P-gp-
mediated efflux of drugs in order to restore their intracellular cytotoxicity in 
tumors. Those compounds are called reversers, modulators or chemosensitizers. 
However, the main cause for the inefficiency of many modulators is their 
behavior as pseudo-substrate that only lower the rate of anticancer-drug efflux. 
Hence, a permanent effect would require high concentrations of such compounds 
which would cause unendurable side-effects, such as cardiotoxicity and 
hypotension for verapamil, or immunosuppression for cyclosporin A (Seelig, 
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1998). The search for the modulators which are not transported by P-gp has 
therefore become an attractive target. Hydrophobic steroid derivative such as 
progesterone was shown not to be transported but to behave as strong modulators 
of drug efflux (Barnes et al., 1996). The modulatory effect of steroids is directly 
correlated to the hydrophobicity of their substituents. Moreover, flavonoids 
constitute another class of modulators thought not to be transported by P-gp 
because findings strongly suggest that the ATP sites of P-gp serve as binding 
sites for flavonoids (Shapiro & Ling, 1997). Therefore, one may suggest that the 
ability of HK-18 to escape from the action of P-glycoprotein may be related to its 
amphiphillic properties. HK-18 may act as a modulator, which is not transported 
by P-gp, and could exert direct cytotoxic effect on tumor cells. However, much 
effort has to be paid in understanding the mechanism of HK-18 to escape from P-
glycoprotein. 
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5.6 Protective Effects of DI AO against Isoproterenol 
(ISO)-Induced Myocardial Injury 
In an attempt to examine the effect of steroid saponins containing drug, DI 
AO, in the cardiac protective effect, the present thesis work was performed. The 
results clearly demonstrated the direct cardioprotective effect of DI AO in in vivo 
and ex vivo models of myocardial injury. Given the involvement of free radical-
mediated processes in the development of IR injury, the cardioprotection 
afforded by DI AO is probably mediated by their antioxidant activities. Further 
investigations indicated that the antioxidant mechanism in the cardioprotection 
likely involves the enhancement of myocardial glutathione antioxidant status. 
In the present study, the beneficial effect of acute DI AO pretreatment on 
the myocardium was examined using an in vivo model of ISO-induced 
myocardial injury in rats. ISO is a potent pi-adrenoceptor agonist. 
Administration of a large dose of ISO (200mg/kg, i.p,) can induce intense 
stimulation of p-adrenergic activity. Under ISO challenge, the rats develop a 
spectrum of pathophysiologic changes that mimic myocardial infarction in 
human. Moreover, autoxidation of ISO wil l generate free radicals that induced 
cardiomyocyte damage. 
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Consistent with these findings, the ISO-induced myocardial injury in rats, 
showed that LDH activities in the plasma was significantly elevated at 4 hours 
after ISO treatment compared to the water control group. DI AO pretreatment 
could produce cardioprotective effect against ISO-induced myocardial injury as 
evidenced by a significant reduction in plasma LDH activities (Fig. 4.4). 
5.7 Cardioprotective Effect of DI AO Against IR 
Injury 
Early reperfusion of ischemia myocardium is now widely adopted as a 
therapy for acute coronary syndromes. However, this method is not risk-free due 
to the presence of reperfusion-induced injury. Ischemia-reperfusion (IR) is 
characterized by the metabolic, electrophysiological, morphological and 
functional derangement as well as by the sudden release of cytoplasmic 
constituents upon reoxygenation of the myocardium after a sustained period of 
ischemia. Among these derangements, ventricular fibrillation, transient 
mechanical dysfunction and myocardial cell death (infarction) has been 
postulated to have pathophysiological importance. It is becoming increasingly 
evident that ROS may play a significant role in the development of cell damage 
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during IR injury (Dhaliwl et al” 1991). 
In the study of the effect of DI AO pretreatment against IR injury, isolated 
rat hearts were perfused by Krebs-bicarbonated buffer using Langendorff 
perfusion technique, with a 30min period of global ischemia followed by a 
15min of reperfusion. To assess the myocardial IR injury, LDH leakage in the 
coronary effluent were monitored. During the reperfusion period following the 
30min global ischemia, a very low cardiac functional recovery (Fig. 4.3) and a 
great extent of LDH leakage (Fig 4.2) were observed. These observations 
indicate the presence of ischemia-reperfUsion damage. Significant improvement 
of contractile force recovery during reperfusion after global ischemia was shown 
by rat hearts prepared from DI AO pretreated animal. In addition, LDH leakage 
during postischemia reperfusion was significantly suppressed by the DI AO 
pretreatment. The results demonstrated that DI AO pretreatment could protect the 
myocardium against IR injury. Owing to the involvement of ROS-mediated 
processes in IR injury, the protection afforded by DI AO pretreatment may be 
mediated by the beneficial effects on myocardial antioxidant status. 
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5.8 Effects of DI AO Pretreatment on Myocardial 
Antioxidant Enzymes Activities and Antioxidant 
Capacity 
Recent experimental evidence suggests that the autoxidation of ISO is 
a source of ROS that can cause myocardial injury. Indirect evidence supporting 
this hypothesis has been put forth for two basic reasons. Firstly, 
nonphysiologically high levels of catecholamines in blood have been found to 
cause ultrastructural and functional damage to the heart. Secondly, compounds 
which can block the binding of catecholamines to the receptor, i.e. P-antagoists, 
protect against the damage caused by ischemia and reperfusion to varying extents. 
In the present study, the myocardial antioxidant enzyme activities (GRD and 
GST) as well as antioxidant capacity assessed by measuring myocardial thiol 
content, in vitro peroxide induced thiol depletion, MDA and TEARS formation 
in rats were examined. 
Under normal conditions, myocardial cells are equipped with a variety 
of cellular defenses against ROS and oxidative stress. Thus, cells can adequately 
deal with the endogenous production of free radicals. However, under conditions 
of IR when cellular defense may be reduced or overwhelmed, the balance 
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between production and catabolism of ROS is upset, free radicals then begin to 
cause cellular damage. 
There are several defense mechanisms against free radicals in 
myocardium. In the enzymatic antioxidants category, superoxide dismutase 
(SOD) belongs to a family of metalloproteins with different prosthetic groups 
(McCord, 1976). They catalyze the reaction that converts superoxide anion 
radical to molecular oxygen and hydrogen peroxide (Freeman & Crapo，1982). 
Catalase is a cytoplasmic heme enzyme. It reduces hydrogen peroxide to water 
and oxygen and thus prevents the formation of more reactive hydroxyl radical. 
2H2O2 2H2O + O2 
Given that myocardial superoxide dismutase and catalase activities are 
much lower than those in other tissues (Doroshaw et al., 1980), the myocardium 
is more susceptible to oxidative damage produced by reactive oxidant species 
(Chen et al” 1994). The glutathione antioxidant system is therefore crucial for 
preventing reactive free radicals damage in the heart. 
Selenium-glutathione peroxidase (GPX) is important for the 
detoxification not only of H2O2 but also of organic peroxide (ROOH) through the 
following reaction: 
ROOH + 2GSH — GSSG + ROH + 即 
、 
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This enzyme catalyzes the decomposition of hydrogen peroxide and organic 
hydroperoxides with the consumption of reduced glutathione (GSH). Unlike 
catalase, GPX is very rich in cardiac muscle and has a higher substrate affinity 
(Kaul et al., 1993). A selenium independent form of glutathione peroxidase, an 
enzyme that catalyzes the reduction of organic peroxide but not hydrogen 
peroxide, belongs to the family of glutathione S-transferases (GST). GST also 
catalyzes the conjugation of electrophilic xenobiotics and their reactive 
intermediates with GSH to produce less toxic products for excretion 
(Morgenstem, 1980). 
The catalytic decomposition of hydroperoxides by GPX or GST is 
associated with the simultaneous oxidation of GSH to its oxidized form (GSSG)， 
which is in turn regenerated by glutathione reductase (GRD). GRD catalyzes the 
regeneration of GSH from GSSG with the expenditure of NADPH generated 
from the pentose phosphate pathway (Paglia & Valentine，1967). 
Besides antioxidant enzymes, there is an array of small molecules in our 
biological system that can quench free radicals directly or act as co-substrates for 
the antioxidant enzymes. GSH is a well known example. GSH, a tripeptide, plays 
an important role in detoxification of ROS arising from oxygen metabolism as 
well as from pathological conditions like IR injury. GSH may act as a reductant 
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which reduces oxidant species with the formation of GSSG (Ross et al., 1985), a 
reaction catalyzed by GPX or GST. It may react directly with oxy-radicals such 
as O2 ， O H and RO •， b y a radical transfer process, yielding the thyl radical, 
GS •，which can eventually form GSSG. 
In the recent experiment, myocardial GRD activities was significantly 
lowered in ISO-treated animal (Fig. 4.5), suggesting the involvement of 
oxidative reactions in the development of ISO-induced myocardial injury. 
Moreover, there was a significantly increase in myocardial GRD and GST 
activities upon DI AO pretreatment. 
On the other hand, myocardial peroxide-induced thiol depletion was 
increased significantly, which also demonstrated the myocardial injury induced 
by the oxidative stress of ISO. Upon DI AO pretreatment, TBARS formed and 
the percentage of peroxide-induced thiol depletion were significantly lowered 
(Table 1). 
Taken together, the results suggest that the cardioprotective action of DI AO 
in ISO-induced myocardial injury were involved in the change in myocardial 
antioxidant status. This is parallel to the result from the earlier ex vivo studies -
Langendorff isolated rat heart system, which indicated that rat hearts after DI AO 
pretreatment had a higher contractile force than the water control. Based on these 
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observations, further mechanistic studies were performed and the results showed 
that the cardioprotective effect of DI AO may be mediated by enhancement of 
both glutathione reductase (GRD) and glutathione S-transferase (GST) activities. 
The enhanced GRD activity was essential for the regeneration of reduced 
glutathione from its oxidized form, thus supporting the enhanced conjugation of 
glutathione (GSH) with organic peroxides by GST. The net result was that the 
percentage of thiol depleted and the TBARS formed upon oxidative challenge 
were significantly reduced after DI AO pretreatment. 
5.9 Conclusion and Future Prospect 
From the present study, results of both in vitro and in vivo experiments 
showed that HK-18 was effective in inhibiting the growth of human 
hepatocellular carcinoma, HepG2 cells. 
The action mechanism of HK-18 is through induction of apoptosis and 
accompanies with G2/M cell cycle arrest. Nevertheless, the relationship and 
sequence between these pathways are not flilly understood. Further investigation 
should be carried out to elucidate the whole picture of the action mechanism of 
HK-18 on HepG2 cells and other tumor cells. 
The recent results also showed that HK-18 was effective in inhibiting the 
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growth of multidrug-resistant human hepatocellular carcinoma, R-HepG2, via 
induction of apoptosis together with G2/M cell cycle arrest. In fact, it is of 
clinical significance to test whether HK-18 is effective in the treatment of other 
multidrug resistant tumor cells. This may help explore the use of HK-18 in 
treating multidrug-resistant patients. 
In order to use HK-18 in cancer treatment, study of its pharmacokinetic 
properties and dosing schedules should be further investigated. Moreover, 
combined treatment with other conventional anti-cancer drugs should be carried 
out. This can help extend the use of HK-18 in cancer therapy. 
To conclude, HK-18 was found to be an effective anti-cancer drug in the 
present study. However, its use in cancer treatment is still controversial because 
of its probable toxicity toward normal tissues although we have found that HK-
18 is non-toxic to heart in present study. Thus, to fully utilize HK-18 in cancer 
therapy, much more efforts should be paid on the study of its action mechanism, 
pharmacokinetic properties, dosing schedules as well as potential hazards. 
On the other hand, the results clearly demonstrated the beneficial effects of 
DI AO on the myocardium, as indicated by the protection against ISO and 
ischemia-reperfusion induced myocardial injury in rats. In this regard, DI AO 
seems to play a role in protecting the myocardium. The cardioprotection afforded 
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by pretreatment with DI AO may mainly be attributed to their ability to sustain 
the myocardial glutathione-dependent antioxidant system, particularly by 
enhancing the endogenous GRD and GST activity in the cardiomyocytes. 
DI AO has long been recognized as an effective drug for the treatment of 
ischemia heart disease. Current findings regarding the saponins-enrich DI AO 
agree well with this claim. Moreover, the involvement of ROS in the 
pathogenesis of ischemia heart disease or myocardial infarction suggests the 
application of antioxidants in the clinical management of the disease. Saponin 
that derived from Chinese herbs seem to provide a more fundamental antioxidant 
actions in protecting oxidative tissue damage by enhancing the glutathione 
antioxidant defense system. 
The present work may hint an approach in future drug development. A lot of 
traditional Chinese herbs have been effectively and safely used for the prevention 
and treatment of diseases for thousands of years in China. However, most of 
these herbs are not widely accepted by western medicine because of the 
insufficient experimental and clinical data to support their efficacy and safety by 
western standards. With regard to the scientific research on traditional Chinese 
medicine, effective pharmacological screen systems are essential for identifying 
active extracts or compounds from crude drugs. 
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